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1 Summary
1 Summary
The mineralocorticoid hormone aldosterone is a key player in blood pressure
control by the kidney where it induces the transcription of a number of genes
in its target tubules. The aim of this work was to characterize the role that the
potentially aldosterone-induced activating transcription factor 3 (ATF3) plays in
the kidney, specifically in the aldosterone sensitive tubule segments, including the
connecting tubule (CNT) and the cortical collecting duct (CCD). To study the
role of ATF3 in principal cells, the main cell type responding to aldosterone in the
CNT/CCD, mouse cortical collecting duct mpkCCDCl14, cells were transduced
with two lentiviral constructs, allowing Doxycycline-inducible overexpression of
ATF3. Epithelia formed by these cell lines and also by another cell line, mCCDCl6
were analyzed for their transepithelial ion transport characteristics in an Ussing
chamber set-up, but did not provide conclusive results regarding a functional role
of ATF3 expression. Further investigations showed that the previously observed
induction of ATF3 was rather mediated by stress than by aldosterone, both
in vivo in mouse kidney and in vitro in cultured kidney epithelial cell lines.
Specifically, we observed in vitro in mCCDCl6 cells 1 h after a medium change an
upregulation of ATF3 mRNA independent of aldosterone which was also observed
at the protein level. Analysis of signalling pathways potentially mediating this
upregulation of ATF3 upon medium change led to the identification of a rapid
increase in phosphorylation of three different mitogen activated protein kinases
(MAPK) JNK/SAPK1, ERK1/2 and p38. Interestingly, this effect appeared to
be dependent on a low CO2 partial pressure of the replacement medium. in vivo,
we showed that an intra-peritoneal injection of a physiological saline solution
in mice induces an upregulation of ATF3 mRNA in the kidney as opposed to
other organs like brain, colon and heart. The fact that tubular cells of the
aldosterone-sensitive distal nephron were involved in this response and that this
response was translated to the protein level was confirmed by the observation
that the same treatment induced a strong upregulation of ATF3 at the protein
level in CNT/CCD tubule segments selected using a complex object parametric
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analyzer and sorter (COPAS). Finally, metabolic characterization of the ATF3
KO mouse revealed no gross phenotype and showed no impairment of kidney
function compared to wildtype mice. Specifically, ATF3 KO and wild type mice
displayed comparable food and water consumption as well as feces and urine
excretion, even when stressed by water deprivation. Taken together, we conclude
that ATF3 expression is exquisitely sensitive to stress, in particular in the kidney,
as shown both in vivo in mouse kidney tubules and in vitro in mCCDCl6 cells.
It is suggested that in vitro this activation is mediated via phosphorylation of
JNK/SAPK1, ERK1/2 and p38.
6
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2 Zusammenfassung
Das mineralocorticoid Hormon Aldosteron spielt eine Schlüsselrolle in der über
die Niere gesteuerten Blutdruckregulation, wo es in den aldosteron-sensitiven
Tubuli eine Anzahl von Genen induziert. Das Ziel der vorliegenden Arbeit war
es, die spezifische Rolle des potentiell durch Aldosteron induzierten activating
transcription factor 3 (ATF3) in der Niere, genauer im Verbindungstubulus und
im kortikalen Sammelrohr zu untersuchen. Da die Hauptzelle derjenige Zelltyp ist,
der in diesen zwei Nierentubulussegmenten aldosteron-sensitiv ist, haben wir die
kortikale Sammelrohr-Mauszelllinie mpkCCDCl14 mit zwei lentiviralen Konstruk-
ten transduziert, welche die Doxycyclin-induzierbare Überexpression von ATF3
erlauben. Epithelien, die von diesen Zellen und zusätzlich von einer anderen
Zelllinie, mCCDCl6 gebildet wurden, wurden in einem Ussingkammer-Messsystem
auf ihre transepithelialen Ionentransport-Eigenschaften untersucht. Diese Messun-
gen führten jedoch nicht zu eindeutigen Resultaten bezüglich der Rolle von ATF3.
Weiterführende Untersuchungen zeigten, dass die zuvor beobachtete Induktion
von ATF3 eher durch Stress als durch Aldosteron ausgelöst wurde. Dies war der
Fall sowohl in vivo in Mausnieren, als auch in vitro in den kultivierten epithelialen
Nierenzelllinien. Die Untersuchung von Signaltransduktionswegen, die potentiell
zu dieser Aufregulation aufgrund des Mediumwechsels führen könnten, hat eine
erhöhte Phosphorylierung der drei mitogen activated protein kinase (MAPK)
JNK/SAPK1, ERK1/2 und p38 innerhalb von sieben Minuten gezeigt. Interessan-
terweise schien dieser Effekt von einem tiefen CO2-Partialdruck im Ersatzmedium
abhängig zu sein. in vivo konnten wir zeigen, dass die Injektion einer physiolo-
gischen Salzlösung in Mäuse zu einer Erhöhung der ATF3 mRNA in der Niere
führt, während dies nicht der Fall ist im Hirn, der Mucosa des Dickdarms oder im
Herzen. Eine starke Aufregulierung von ATF3 aufgrund der selben Behandlung
konnte auf Ebene der Proteinexpression im Verbindungstubulus und kortikalen
Sammelrohr beobachtet werden, welche mit einem complex object parametric
sorter and analyzer (COPAS) selektioniert wurden. Die metabolische Charakter-
isierung der ATF3 KO Maus zeigte keine gestörte Nierenfunktion verglichen mit
7
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Wildtypmäusen. Auch die Futter- und Wasseraufnahme sowie die Stuhl- und
Urinproduktion waren vergleichbar. Wir ziehen die Schlussfolgerung, dass ATF3
spezifisch in der Niere in vivo ein stress-reguliertes Gen ist und dies auch auch in
mCCDCl6 Zellen in vitro beobachtet werden kann. Diese Aufregulierung kommt
in vitro durch die Phosphorylierung der MAPK JNK/SAPK1, ERK1/2 und p38
zustande.
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General introduction
The rationale of my thesis initially came from experiments made before I joined
the laboratory. The original aim was to identify genes displaying an early response
to aldosterone, and then to determine their effect in aldosterone target cells in the
so-called aldosterone sensitive distal nephron (ASDN). A first Microarray study
made on RNA prepared from isolated tubules of mice injected with aldosterone 1
hour before yielded a list of early aldosterone regulated genes, two of which were
the activating transcription factor 3 (ATF3, 3.5-fold upregulated) and Gremlin2
(Grem2, 7.2-fold upregulated). We sought to determine the role of these two
proteins in aldosterone linked processes. After investing a large part of the time of
this thesis following this aim, we realized these two candidates were not regulated
by the hormone aldosterone itself but rather this effect was a stress-response of the
mice. In the initial experiments, the negative controls (untreated animals) were
literally untreated, meaning they did not receive any vehicle injection and instead
were killed directly1. Furthermore, in vitro experiments with cultured cells showed
that a medium change also induced ATF3 in these cells. An additional experiment
injecting vehicle into mice confirmed our hypothesis that ATF3 was upregulated
by stress. In consequence the project was reoriented towards the mechanism
leading to ATF3 induction. Interestingly, this stress response turned namely out
to be quite organ specific; being strong in the kidney, and not significant in other
organs tested. This suggests that the response is specific and that there could
be a rationale for it to be seen exclusively in the kidney. Because much of the
work performed during this thesis was done based on the rationale that ATF3 is
1Practically tubules from three treatment conditions had been originally isolated and tested:
from mice injected with aldosterone, canrenoate (MR antagonist) or not injected. Because
of the observation that the canrenoate treatment per se induced some gene products, it had
been decided to focus on the genes that were differentially expressed between aldosterone-
injected versus not injected conditions.
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regulated by aldosterone, I will now introduce the kidney, aldosterone and also
lentiviral inducible expression systems, since we produced clonal kidney cell lines
overexpressing ATF3, and that this same approach was then used by others to
characterize their protein of interest.) In the later parts of the introduction, I will
focus on the basic leucine zipper transcription factors, to which the ATF3 protein
belongs and signalling cascades that induce ATF3 under stress conditions.
3.1 Anatomy and function of the kidney
In humans, the kidneys are paired bean-shaped organs of about 10 cm in length,
which primarily serve the function of urine production and are of central im-
portance for maintenance of body homeostasis (e.g. electrolyte balance, blood
pressure control, acid-base regulation and excretion of metabolic waste products).
In adults, each kidney weighs about 115-170 g. Blood enters the kidney via
the renal artery and leaves it over the renal vein. The organ consists of two
basic layers, namely the cortex (granular outer region) and medulla (darker inner
region). A lot of so called glomeruli are found in the cortex, they are the reason
for its granularity. Glomeruli are bundles of capillaries that form the primary
urine by filtering the blood. The medulla being free from glomeruli is made up in
humans by 8-18 conical pyramids constituted by a parallel arrangement of small
blood vessels and tubules. The tip of each pyramid is perforated, which allows
the urine to enter the renal sinus.
The kidneys receive 20% of the total cardiac output and produce around 170
liters of primary urine (ultrafiltrate) per day. The urine is transported from each
kidney to the bladder via the ureters.
The functional unit of the kidney is the nephron. Each human kidney is made
up of 800’000 to 1’2000’000 nephrons. The nephrons all function individually up
to the point where the collecting ducts merge with the collecting duct of one or
even several other nephrons.
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A nephron is constituted of a glomerulus and a tubule. The glomerulus is a bundle
of blood vessels that forms the ultrafiltrate from the urine. This ultrafiltrate
is passed on into the so-called tubule; an epithelial structure showing many
ultrastructural subdivisions with specific functions to convert the blood filtrate
into urine. Thus, the nephron has a vascular component as well as an epithelial
one. They both converge in the so-called Bowman’s capsule which surrounds
the glomerulus and is contiguous with the lumen of the proximal end of the
tubule, where the ultrafiltrate is taken up from the blood. There are two types
of nephrons: superficial nephrons that have short loops extending only onto
the border between outer and inner medulla and medullary nephrons which are
important for the concentration of the urine and have long loops reaching the tip
of the medulla [1].
The tubule of the nephron is subdivided into specialized segments which carry
out very specific roles in the concentration of the primary urine due to specialized
transporters that are characteristic for this segment. The tubule starts with the
proximal tubule (see Fig.1). First, the proximal tubule is convoluted (proximal
convoluted tubule: PCT, alternatively categorized as S1 and S2), and then
straightens along the way to the more distal parts of the tubule (proximal
straight tubule: PST, alternatively S3). In the proximal tubule the apical
membranes of the epithelial cells that line the tubule show many infoldings, this
is called the brush border membrane. Due to its variety of inserted transporters
it allows high reabsorption of amino acids, glucose, certain ions (e.g. Na+ Cl-,
HCO3- Ca2+) and water but is also responsible for secretion of NH4+ and other
solutes. Adjacent to the proximal tubule is the loop of Henle (subdivided into thin
descending limb, thin and thick ascending limbs). This loop is mainly involved in
the dilution or concentration of the urine by building up a hyperosmotic gradient
in the medulla by juxtamedullary nephrons. Depending on the body’s needs, the
gradient can be used to concentrate the urine in the distal medullary collecting
ducts if necessary.
The loop of Henle terminates at the so called macula densa, which is part of the
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juxtaglomerular apparatus (JGA). The JGA is important for the regulation of
filtration rate, blood flow, sodium balance and maintenance of systemic blood
pressure. The macula densa is the region where the thick ascending limb touches
its glomerulus. It is made up by specialized epithelial cells lining the wall of the
tubule, having large nuclei and being closely packed. This is the reason why
this region of the tubule appears to be more “dense” when analyzed with a light
microscope.
Granular cells are specialized smooth muscle cells lining the walls of the afferent
arteriole in the JGA. They produce and store the renal hormone renin. Upon
registration of a drop in blood pressure in the JGA, renin is released from
the granular cells to regulate blood pressure via the mechanisms of the renin-
angiotensin-aldosterone-system RAAS (see 3.1.1) [1].
The fine control of water and salt excretion takes place in the distal tubule and
collecting duct system. The distal convoluted tubule (DCT) begins at the macula
densa and merges into the connecting tubule (CNT) which ends in the cortical
collecting duct (CCD). The CNT and collecting ducts show two distinct cell
types, the principal cells and the intercalated cells, which are further subdivided
into α- and β- intercalated cells. Principal cells constitute about two thirds of the
initial and cortical collecting tubules; they have a characteristic central cilium on
the apical membrane and are responsible for Na+ and Cl- absorption as well as
K+ secretion. α -intercalated cells secrete H+ while β- intercalated cells secrete
HCO3-. The collecting duct branches of several nephrons join to form the cortical
collecting tubule (CCT) further divided into the outer medullary collecting duct
OMCD and inner medullary collecting duct IMCD (see Fig. 1) [1].
12
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Figure 1: Structure of the nephron. Figure taken from the Textbook Boron & Boulpaep
Updated Edition 2005 [1]
3.1.1 The Renin-Angiotensin-Aldosterone System RAAS
The Renin-Angiotensin-Aldosterone System RAAS is a hormone system regulating
salt and water homeostasis of the human body by influencing the cardiovascular
system (blood pressure) in parallel with kidney function (salt retention/water
excretion/blood volume control).
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Angiotensin
Angiotensinogen (“renin substrate”) is synthesized in the liver and constitutively
released into the blood circulation. Renin, a protease produced and stored
in the granular cells of the JGA of the kidney, cleaves the deca-peptide from
Angiotensinogen to Angiotensin I (Ang I). Renin is released from the granular
cells of the macula densa (specialized smooth muscle cells in the wall of the
afferent arteriole proximal to the glomeruli) when there are decreases in effective
circulatory volume and subsequently also in blood pressure. This drop can be
sensed by several systems:
• Decreased systemic blood pressure: Baroreceptors located in the central
arterial circulation sense the decrease, signal the medulla to increase the
sympathetic outflow to the JGA
• Decreased renal perfusion pressure: Stretch receptors in granular cells of
the afferent arterioles sense a decreased distention
• Decreased luminal NaCl concentration at macula densa (independent of
renal nerve activity)
All of the above mentioned control mechanisms lead to an increase in Renin
release, enhancing the Ang I levels in the circulation. Ang I is still an inactive
molecule, it needs to be cleaved into active Angiotensin II (Ang II) by the
dipeptidyl carboxypeptidase angiotensin-converting enzyme (ACE), which is
found on the luminal surface of vascular endothelia throughout the whole body,
but mostly prominently resides in the lungs [2]. Ang II is the most potent effector
of the RAAS; it has vasoconstrictive, pro-inflammatory and pro-fibrotic properties.
There are two receptors for Ang II. Most actions of Ang II are mediated upon
binding to the angiotensin receptor1 (AT1) (see Fig.2). This includes aldosterone
secretion form the adrenal gland, vascular smooth muscle constriction, adrenergic
14
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stimulation and sodium retention. Ang II is able to counterbalance its own
actions by binding to the AT2 receptor, which triggers NO release, leading to
vasodilatation [1]
 
Figure 2: Scheme of the renin-angiotensin-aldosterone system RAAS. Scheme by Ham-
ming et al. 2007. [3]
The main function of Ang II is to balance effective circulatory volume by control-
ling Na+ reabsorption through the following mechanisms:
• Stimulation of aldosterone release from the glomerulosa cells of the adrenal
cortex leading to Na+ reabsorption via the epithelial sodium channel (ENaC)
in the so called aldosterone sensitive distal nephron (ASDN, see 3.1.2.)
• Reduced blood flow through the vasa recta prevents NaCl and urea from
being washed out of the medulla
15
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• Stimulation of Na/H exchangers (proximal tubule and thick ascending limb
of loop of Henle) promotes Na+ reabsorption
• Stronger constricting the efferent arteriole compared to the afferent one
maintains filtration rate and then supports Na+ reabsorption in the proximal
tubule
• Stimulation of thirst sensation in hypothalamus and release of the peptide
hormone arginine vasopressin (AVP, also called anti-diuretic hormone ADH)
from the posterior pituitary leading to an increase in total-body free water
• Enhanced tubuloglomerular feedback (see Fig 3) [1].
An increase in total-body free water and Na+ retention result in a raise of blood
pressure.
Aldosterone
Aldosterone regulates salt and water homeostasis. As mentioned earlier, aldos-
terone is released from the so-called granulosa cells of the cortex of the adrenal
gland upon renin secretion and subsequent Ang II production as a response to a
drop in blood pressure (see Fig. 3). It is a mineralocorticoid hormone belonging to
the class of steroid hormones, since it is synthesized from cholesterol. Aldosterone
production is unique to granulosa cells because they are the only cells in the
body producing the aldosterone synthase, an enzyme needed for the last step of
aldosterone creation. The synthesis and release of the mineralocorticoid hormone
is tightly regulated by several factors. Apart from Ang II, elevated plasma K+
levels also stimulate the production and release of aldosterone. K+ depolarizes
the membrane of granulosa cells, triggering an intracellular signalling cascade
that finally leads to aldosterone secretion [2]. In turn, aldosterone increases the
16
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renal secretion of K+ in a negative short feedback loop.
 
Figure 3: Schematic representation of coupling of vascular and renal system through
the renin-angiotensin-aldosterone axis. Figure by Rad et al. 2006. [4]
Aldosterone also regulates Na+ retention in the kidney in the principal cells of the
collecting ducts. In the current definition, the aldosterone sensitive distal nephron
(ASDN) includes the late distal convoluted tubule (DCT2), the connecting tubule
and the cortical collecting duct (see Fig. 4) [5]. The ASDN is the most important
site of fine-tuning for salt and water reabsorption. In this part of the nephron,
ENaC, 11-β-hydroxysteroid dehydrogenase type 2 and the aldosterone receptor
mineralocorticoid receptor (MR) are co-expressed. The target cells for aldosterone
are the principal cells of the collecting duct, even though also intercalated cells
have been shown to be to some extent responding to aldosterone action [6].
17
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Figure 4: The aldosterone sensitive distal nephron ASDN. Scheme by Gabriele Adam
(PhD), 2007 (unpublished).
Since aldosterone is a steroid hormone it can freely diffuse through the plasma
membrane of the principal cell. In the cytoplasm the hormone binds to its
receptor, the mineralocorticoid receptor (MR). This complex then translocates to
the nucleus and initiates or inhibits transcription of target genes. It is known that
the proteins induced by aldosterone are involved in regulation of Na+ retention
(see Fig. 5). For example they act on ENaC, enhancing the number of channel
molecules in the plasmamembrane, stabilizing them and preventing them from
being ubiquitinated and internalized into the membrane [7]. The increase in Na+
absorption form the kidney tubules causes enhanced retention of water which
elevates the extracellular fluid volume, which rises arterial pressure.
18
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Figure 5: Action of aldosterone: Aldosterone freely diffuses through the membrane (steroid
hormone) and binds to the cytoplasmic mineralocorticoid receptor (MR). This complex translo-
cates to the nucleus and binds to specific regions in promoters of target genes. The transcription
of the target gene is enhanced or suppressed, the protein products of these genes are involved
in sodium retention via the epithelial sodium channel ENaC. Scheme by Gabriele Adam (PhD),
2008 (unpublished).
Thus aldosterone as well as Ang II is very important for control of blood pressure.
The RAAS is often involved in cases of hypertension. For example when patches
of the kidney are not properly supplied with blood, they start to constantly
secrete high amounts of renin, Ang II is formed, aldosterone is released and the
kidney starts to reabsorb big amounts of Na+ and water, leading to a permanent
rise in blood pressure and eventually tissue damage. In obese patients, Ang II and
aldosterone are significantly higher than in slim people. The reason for this might
be an elevated sympathetic nerve stimulation that leads to secretion of Renin,
triggering the RAAS cascade. Today hypertension is treatable with different
drugs. Vasodilative drugs either inhibit sympathetic nerve signals that would
19
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cause Renin release or they directly relax the smooth muscle of the vasculature
in the kidney. Another effective way of regulating blood pressure is by blocking
the Ang II receptor or using ACE inhibitors.
3.2 Basic leucine zipper (bZIP) transcription factors
In our initial experiment with mice injected with aldosterone, we found the basic
leucine zipper (bZIP) transcription factor ATF3 to be upregulated [7] and it was
only later that we came to the conclusion that this induction was stress-related.
I will describe the bZIP transcription factor family with a special emphasis on
ATF3, and will also give a short insight into ATF3 in stress-responses.
The mammalian ATF/CREB (activating transcription factor/cAMP responsive
element- binding) family of transcription factors constitutes a large group of basic
region-leucine zipper (bZIP) proteins. The basic region of the bZIP domain is
the DNA binding domain of this kind of transcription factor, which was classified
in the late 1980s. The leucine zipper contains a coiled coil structure with heptad
repeats of leucines. When the hydrophobic leucine occurs at every seventh
position of an α-helix, the aliphatic side-chains are all oriented on the same side
of the helix so that they can interact with each other, leading to a coiled coil
structure (see Fig. 6) [8]. The leucine zipper of the bZIP domain is responsible
for transcription factor dimerization.
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Figure 6: Schematic representation of the bZIP domain bound to double stranded
DNA: DNA is represented in red, bZIP helices are in blue, heptad repeats of leucines are
depicted in grey. Figure by Manna et al. 2009. [20]
The bZIP transcription factors represent one of the most important classes
of enhancer-type transcription factors; they play a role in many physiological
processes such as development, differentiation, tumor progression, metabolism
and stress [9] [10]. There are three subfamilies of bZIP transcription factors: (1)
cAMP responsive element-binding/ cAMP responsive element modulator/ ATF1
(CREB/CREM/ATF1), (2) Fos/Jun and (3) Caat-enhancer-binding protein
(C/EBP), they all form (homo- and/or hetero)dimers, but bind to different DNA
sequences unique to each subfamily. The bZIP domain allows selective formation
of homo- and/or heterodimers among family members. Electrostatic interactions
between amino acids along the dimerization sequence favor either the homo-
or heterodimerization [11] [12]. The dimers then recognize related palindromic
sequences in the DNA. Up to date as much as 53 human genes have been found
to contain bZIP motifs which lead to a potential of 2700 different dimers to be
formed [13] [14]. The heterodimeric complexes formed between jun, Fos and
ATF family members are called AP-1 transcription factors. These AP-1 dimers
are subdivided into 2 distinct classes, Jun/Fos and Jun/ATF. Depending on the
combination of transcription factors involved, they can regulate cell proliferation,
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differentiation and apoptosis either positively or negatively [15].
Expression and effects of the bZIP proteins are controlled by several signalling
pathways, including cAMP-dependent protein kinase A (PKA), PKC, TGF-β
signalling [16] and mitogen activated kinases MAPK such as the extracellular
signal-regulated kinase (ERK), c-jun-N-terminal Kinase JNK and p38 kinase
[17] [18] [19]. Depending on the cell type, its malignancy status and also the
environment the cell faces, certain bZIP proteins are upregulated and interact
with the transcriptional control of different targets genes.
In the following I would like to take a closer look at the ATF transcription factor
family, with special emphasis on ATF3.
3.2.1 Activating transcription factor ATF
All proteins belonging to the ATF/CREB family have in common that they are
responding to extracellular signals.
There are many cellular proteins having potential ATF binding sites in their
promoters. ATFs in most cases bind to the so called cAMP response elements
(CRE) in the promoter of the target gene. The CRE is required for gene
inducibility via cAMP signalling [21]. The consensus binding sequence of all
ATFs is 5’-TGACGTCA-3’. There are also promoters that are not responsive to
cAMP that are bound by ATFs.
Truncated versions of ATFs leaving them only with their bZIP domain have been
shown to bind DNA. In order to bind to DNA, it is required for the ATF proteins
to dimerize. All of the 8 different ATF proteins can homodimerize, however, not
all combinations of ATF proteins can heterodimerize [22]. Heterodimerization
partners of ATF3 are C/EBP, CHOP/DDIT3, ATF2, Jun, JunB, p21SNFT/JDP1,
and Nrf2/NFE2L2. Depending on the different dimerization patterns, ATF
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proteins can be activators of gene expression, while in another combination
they would rather be repressors. For example homodimers of ATF3 rather
suppress gene transcription. Furthermore ATF/CREB family members can also
heterodimerize with bZIP proteins belonging to other transcription factor families,
e.g. AP-1 or C/EBP family members. This leads to a tremendous possibility of
combinations of heterodimers, which are believed to have differing DNA binding
specificities and therefore pleiotropic effects on gene expression regulation [23].
All ATFs show high sequence similarity in their leucine zipper and adjacent basic
domain, however, outside of this region, they can be quite diverse in amino acid
sequence [22]. Nowadays the ATF/CREB family of transcription factors is further
subdivided into 6 subgroups, based on their amino acid similarity (see Table
1). Members of the same subgroup show significant sequence similarity inside
as well as outside of the bZIP subdomain. Between the groups, the proteins do
not share much similarity other than the bZIP motif. Hence, even though they
have the same prefix (e.g. ATF or CREB), they should indeed be considered as
distinct proteins [24]. However, some names of the proteins rather reflect their
history of discovery rather than the belonging to one family. For example, ATF3
is much more homologous to the fos proteins (which belongs to the AP-1 family)
rather than to other subgroups of the ATF/CREB proteins [11]. Also proteins
belonging to one family can regulate transcription in the manner of the other
family, e.g. C/EBP proteins can activate certain promoters by binding to a CRE
site instead of the C/EBP site [25].
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Table 1: The mammalian ATF/CREB family of transcription factors with its 6 sub-
groups: Due to historical reasons, the nomenclature of the ATFs shows many different
synonyms for each protein. This table is not comprehensive. Table by Hai et al, 2001. [24]
3.2.2 ATF3
ATF3 was originally isolated from HeLa cells that were treated with tetrade-
canoylphorbol acetate (TPA) which is a potent tumor promoter often employed
in biomedical research to activate the signal transduction via protein kinase C
[22]. ATF3 is a 181 amino acid protein that is ubiquitously expressed but its
level is maintained low in the absence of cellular stresses [26], residing in the
nucleus. Upstream factors of ATF3 include for example p53 [27], ATF2 [15],
ATF4, protein kinase A (PKA), HIF-1a, the mitogen-activated kinases (MAPK)
and C/EBP. Therefore ATF3 is regulated on the RNA level (e.g. by ATF4) as
well as posttranslationally modified (e.g. by phosphorylation by MAPK) [28].
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The ATF3 homodimer is a transcriptional repressor while heterodimeric complexes
of ATF3 with c-Jun have been demonstrated to act as activators of transcription.
Other bZIP protein dimerization partners for ATF3 are ATF2 [22], c-Jun [29],
JunB [30], JunD [31] and gadd153/CHOP10. Transient transfection experiments
have shown that ATF3/c-Jun and ATF3/JunD activate promoters containing
ATF/CRE or related sites, while ATF3/JunB can either activate or repress a
promoter, depending on the promoter context [30].
There are two different splice variants of ATF3 in humans: The longer isoform
represses rather than activates transcription from promoters with ATF binding
elements. The two shorter isoforms (∆Zip and ∆Zip2 see Fig.7.) lacks the
bZIP motif and therefore does not bind to DNA [32]. It is believed to sequester
co-repressors from the promoters of the target genes, therefore activating their
promoters. The full length form of ATF3 is also capable of activating promoters
that do not contain ATF3 binding sites, probably also due to keeping away
negative factors from the promoters of target genes [33]. In mice, so far only
one isoform of ATF3 was identified (corresponding to the longer one in humans).
ATF3 is early (within 2 h) and transiently induced during cellular responses to
stress [28].
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Figure 7: Isoforms of the ATF3 transcript in humans: The ATF3 gene has two promoters
P1 and P2 that are differentially activated by external stimuli such as growth factors. The
P1 and P2 transcripts differ in the first exon but share common exons 2, 3, and 4 encoding
the same protein sequence. Both promoters give rise to the same transcripts, however, these
proteins can be spliced differentially. The full length protein is made up of 181 amino acids,
containing the basic region which binds the DNA and the bZIP region, which is the leucine
zipper that allows dimerization of ATF3 either with itself (homodimerization, leading to a
negative regulator of transcription) or other bZIP proteins, including the ones from other
families e.g. c-Fos [34]. The ∆Zip and ∆Zip2 splice variants of the protein are shorter, due
to a lack of the bZIP domain. Therefore these isoforms cannot dimerize, which leads to an
inability to bind DNA. Thus, these two isoforms of ATF3 have a rather activating function on
target genes, due to potential sequestering of transcriptional co-repressors. Figure by Kitajima
et al, 2009 [34].
ATF3 in stress responses
There is overwhelming evidence from many laboratories that ATF3 is an early
stress-inducible gene, its mRNA expression increases dramatically when cells are
exposed to stresses such as amino acid deprivation [35] [36] [37], UV irradiation
[38], x-rays [39], hypoxia [40] [41], ischemia-reperfusion injury in kidney [42],
toxins like LPS via interferons [43] [44], cytokine release such as TNFα [19] or
interleukin 4 (IL-4) [45] and many other stressors. All stressors seem to have
in common that they injure the cell. Stresses that do not injure the cell seem
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to fail to induce ATF3 transcription [46]. ATF3 is induced very immediately
when the cell faces the stress and its induction remains only transient. In most
of the systems that have been examined so far, a transient induction of ATF3
mRNA is seen within 2 h. This early and transient induction suggests that there
is a mechanism to turn off ATF3 expression after its induction. Indeed it has
been shown that ATF3 being a transcriptional repressor can shut down its own
transcription by binding to its promoter [47]. Many of the target genes of ATF3
might themselves be other transcription factors, to orchestrate an early stress
response of the cell.
Up to date there are around 40 target genes of ATF3 known, including inter-
leukins, the inhibitor of differentiation 1 (Id1) [48], the transcription factor Nrf2,
the nuclear protein gadd153/CHOP10 [49] [50], cyclin D1 which controls cell
cycle arrest and phosphoenolpyruvate carboxykinase [51] which is important in
gluconeogenesis. ATF3 also has a target site in its own promoter, repressing its
own transcription via a negative feedback loop [47]. This explains partially the
transient nature of ATF3 induction. Also other bZIP proteins like c-Fos [52] or
ICER [53] show this autorepression.
Signalling pathways acting on ATF3 expression include TGF-β signalling, p53-
dependent signalling, protein Kinase A (PKA), nuclear factor kappa B (NF-κB)
and the mitogen activated kinases (MAPK). MAPK are activated by upstream
kinases in response to extracellular stimuli like growth factors, hormones, stress
and cytokines. There are 4 major signalling pathways via the MAPK ERK1/2,
the p38, the c-Jun-N terminal kinase (JNK) and ERK5, which then in turn act
on transcription factors by phosphorylating them regulating their transcriptional
activity (see. Fig.8). The MAPK can be differentially involved in the regulation
of ATF3 expression: JNK and p38 kinase seem to upregulate ATF3 mRNA
expression, while it is suppressed by the extracellular-signal related kinase (ERK)
[19].
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Figure 8: The four major MAPK signalling pathways. Scheme by Roberts et al. 2007
[54].
The physiological role of ATF3 is still controversially discussed. Targeted disrup-
tion of ATF3 in mice causes no obvious phenotype; the animals are viable and
grow normally [55]. ATF3 was first believed to have detrimental outcomes for the
cell when it is expressed. This was shown in several overexpression systems in
vitro but also in vivo in flies and mice. However this ectopic expression is entirely
out of context and ATF3 effects depend strongly on other proteins that might be
induced and interact with ATF3. Nevertheless, ATF3 seems to be involved in
tumor progression, promoting metastasis [56] by supporting cell cycle progression
[30] [57]. A big variety of cancers including solid tumors in the breast, lungs,
prostate and colon overexpress ATF3, supporting the notion that ATF3 is a
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tumor progressor and positive regulator of cell cycle progression and cell survival.
Under other conditions using other cell lines, ATF3 seems to have the opposing
function, supporting cell death and preventing tumorigenesis. ATF3 is a marker
for injured neurons that are regenerating [58] and is activated by JNK when
cerebellar granule neurons undergo apoptosis due to potassium deprivation [59].
Another example of ATF3 dependent apoptosis is observed in beta cells of the
pancreas, where ATF3 suppresses the expression of the insulin receptor substrate
2 (IRS2), resulting in cell death [60]. So the effects of ATF3 seem to clearly
depend on the cell type and also its malignancy status. The group of Tsonwin
Hai, which created the ATF3 knockout mouse was the first to state a dichotomous
role for ATF3 in cancer development. They performed loss- and gain of function
studies using a breast cancer cell line (MCF10A) that comes in different sub-states
of malignancy but all of them have the same genetic background. MCF10A is
spontaneously immortalized but shows normal characteristics of breast epithelium
whole MCF10CA1a is a highly malignant form of this breast epithelial cell line.
In the non-malignant MCF10A cell line, ATF3 enhanced apoptosis, while in the
aggressive MCFCA1a it protected from apoptosis, enhanced the cell motility
and upregulated the transcription of genes involved in metastasis formation
e.g. caveolin-1, Slug and the Basic helix-loop-helix (bHLH) transcription factor
TWIST1 [61].
ATF3 regulation in the kidney
In an initial experiment that was at the origin of the present thesis work, it
was sought to determine aldosterone regulated genes in the aldosterone sensitive
distal nephron using the Affymetrix Microarray approach. The strategy was to
inject mice with aldosterone for 1 h, to micro-disect the tubules of the ASDN
and to extract total RNA from the tissue. This RNA was then subjected to
Microarray analysis, yielding a list of potentially aldosterone regulated genes. In
this list we found ATF3 mRNA to be upregulated 3.5-fold. Only later we realized
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that this upregulation was not due to the specific effect of the mineralocorticoid
hormone but rather to the injection per se, manifested in the stress reaction of
the mouse to being restrained and injected. This seemed to be reasonable since
the literature comprises many papers dealing with the role of stress induction
of ATF3 as mentioned earlier. Interestingly the induction of ATF3 by stress
seemed to be very specific for the kidney and might even be specific for this
kidney segment (the ASDN). An induction of ATF3 under the same treatment
conditions was not seen in heart or colon.
According to the literature, only little is known about the specific function of
ATF3 in the kidney. Nevertheless it has been found to be involved in stress-
reactions of the kidney. It is upregulated 12-fold in human proximal tubule
(HK2) cells treated with hydrogen peroxide H2O2 (oxidative stress) and 6-fold
in a mouse model of renal ischemia-reperfusion injury, which is an insult that
usually leads to subsequent apoptosis of tissue. Overexpression of ATF3 could
reduce the injury, which was associated with a decrease in p53 [42]. ATF3 was
found in urinary exosomes of rats with cis-platin injury or ischemia-reperfusion
injury. Exosomes are secreted vesicles from all nephron segments that contain
intracellular kidney injury biomarkers. Also human patients with acute kidney
injury excrete ATF3 containing exosomes in the urine, in contrast to patients
with chronic kidney failure, where there is no ATF3 detected in the urinary
exosomes, suggesting that ATF3 might be a new marker for renal acute injury
[62]. This is also supported by another study in acute renal failure (ARF) models
in rat kidney, where ATF3 was transiently upregulated not only on the mRNA
but also on the protein level after 8 h and 24 h in whole kidney samples [63].
The before mentioned studies only show the upregulation of ATF3 in kidney
injuries due to hypoxic stress, toxic stress and as a result of this eventually
apoptosis, but they never propose a mode of action of the transcription factor in
these pathophysiological conditions. Therefore the group of Guanghui Hu sought
to unify all the Microarray data available and tried to reveal possible signal
transduction cascades involved in human kidney pathologies. They found ATF3
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mRNA to be induced by the TGF-β signalling pathway, which is involved in many
diseases (e.g. glomerular- and tubulointerstitial pathologies) and also controls
many processes in the kidney [64]. It regulates the basal expression of collagen
IV which is the main constituent of the basement membrane of the glomerulus.
ATF3 has been reported to repress expression of type IV collagenase (matrix
metalloproteinase-2 MMP-2) by inhibiting trans-activation of the MMP-2 gene
by p53 [65]. Therefore it is reasonable to suspect ATF3 to possibly contribute
to TGF-β mediated kidney diseases by interfering with the healthy balance of
collagen production and breakdown.
TGF-β is linked to renal dysfunction during diabetes-induced processes (e.g.
diabetic nephropathy via hypertrophy matrix accumulation), in which an excessive
production and secretion of glucagons takes place (the hormone which is the
counter-regulator of insulin). ATF3 has been shown to act positively on the
expression of glucagons in several cell types [66], therefore possibly being a player
taking part in the events that lead to kidney end stage disease. In addition,
ATF3 gene expression was reported to be up-regulated by TGF-β- treatment in
epithelial cells [48].
Not only will TGF-β-induced ATF3 decrease MMP-2 mRNA transcription and
enhance glucagon secretion, in addition it also acts on Cyclin D1 which is an
important control protein in cell cycle progression. Cyclin D1 allows the cell to
go from the resting G1 phase into the S-phase. In mouse chondrocytes ATF3
represses the expression of Cycline D1 [67], leading to a cell cycle exit, prevention
of cell division and subsequent terminal differentiation, which can result in
hypertrophy of the kidney tissue.
There could be two different pathways via which ATF3 is upregulated by TGF-
β. One pathway involves the MAPK p38 which was mentioned earlier. p38
phosphorylates the heterodimer of c-Jun and ATF2 which in turn translocates
to the nucleus and induces the transcription of the ATF3 gene by binding to
the ATF/CRE site in its promoter region [32]. The other pathway would be
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the more classical pathway over the so-called Smads. Smads are transcription
factors involved in TGF-β signalling. Smad3 is phosphorylated upon binding of
TGF-β to its receptor, then it binds the co-Smad4, translocates to the nucleus
and initiates ATF3 transcription (see Fig. 9).
 
Figure 9: Proposed regulation of ATF3 by TGF-β signalling in the kidney: There is a
possible regulation of ATF3 gene transcription via a Smad dependent and Smad independent
pathway. Both regulation pathways are mainly controlled by phosphorylation rather than gene
expression. On the contrary, once the ATF3 is activated, it stimulates or suppresses a number
of down-stream genes involved in many biological processes and kidney diseases such as fibrosis,
hypertrophy, and diabetic nephropathy. Scheme by James et al. 2006 [64].
So far only the negative role of ATF3 with detrimental outcomes for the kidney
was discussed. However, there is also evidence that ATF3 can exert a protective
role for the kidney cells. A very recent study showed that ATF3 deficient mice have
a higher ischemia-reperfusion induced mortality, as well as kidney dysfunction,
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inflammation and apoptosis. When they specifically rescued ATF3 expression
in the kidney, the ischemia-reperfusion injuries were reduced. Here ATF3 seems
to be regulating interleukin 6 and 12 expression in an epigenetic way: ATF3
directly binds to the histone deacetylase 1 (HDAC1) and recruits the enzyme to
the ATF/NF-κB sites of the promoters of the two interleukins. The DNA in this
region then condensates which makes it harder for transcriptional co-factors and
the RNA polymerase to reach promoter. This leads to an epigenetic repression
of IL6 and 12 in acute kidney injuries, mediated by ATF3 [68]. As mentioned
earlier, the human kidney cell line HK2 increases ATF3 expression upon H2O2
treatment. When ATF3 was introduced into this cell line using adenoviruses,
the cells were protected from apoptosis in a p53-dependent manner. When
overexpressing ATF3 in mice using the same viruses, the animals were protected
from ischemia-reperfusion injury [42].
Thus, just like for its involvement in cancer, one cannot make a clear statement for
ATF3 mediated effects in the kidney, they might be very controversial depending
on the insult. Many papers describe ATF3 as a promising novel target for treating
kidney injuries. However, it is not always the “bad guy”, which makes it harder
to use as a therapeutic target.
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3.3 Retroviruses
Since we used lentiviral vector systems for this study, in the following an overview
of lentiviruses is provided.
General introduction
Over the last few years, virus-based vectors have become very important tools for
research using overexpression systems. They have also been implicated in first
attempts of gene transfer to diseased cells, trying to genetically cure illnesses. Also
due to the very high transduction rate, they have been used to create transgenic
animals [69]. Nowadays, various types of virus-derived gene transfer systems are
available based either on DNA or RNA viruses. The vectors either integrate
stably into the host cell genome or express their genetic information episomally
(replicating autonomously in the cytoplasm or as part of a chromosome).
Retroviruses have been used since the early 1990s to transfer DNA into host
cells. As already described in 1970, retroviruses are single-stranded RNA (ss)
viruses replicating through a double-stranded (ds) DNA intermediate [70]. They
display a broad host range, including humans and many other mammals as well
as birds. Some of the earliest ever studied retroviruses were the murine leukaemia
virus (MLV), mouse mammary tumor virus (MMTV) and avian leucosis virus
(ALV). All of them were found to associate with tumor development in their host
organisms, which made them very interesting for studying cancer development.
They helped to discover the oncogenes. While some viruses seemed to deliver
oncogenes to the cell, others were interacting directly or more indirectly with the
oncogenes encoded by the host cell, therefore contributing to malignant tissue
formation [71].
Based on their pathogenicity the retroviruses were divided into three groups: (1)
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the onco-retroviruses (e.g. MLV), (2) the lentiviruses (e.g. human immunode-
ficiency virus HIV) and (3) the spumaviruses (foamy viruses, with prominent
spikes on their surface e.g. human foamy virus) [72]. In the following lentiviruses
shall be discussed closer.
3.3.1 Lentiviruses
Lentiviruses (latin: slow) have long incubation periods and characteristically
cause diseases with a prolonged latent period. Lentiviruses (e.g. Human im-
munodeficiency virus HIV) have the ability to infect a broad range of dividing
and non-dividing host cells and stably integrate DNA segments into the cell
genome. The lentivirus docks to the target cell surface and releases RNA into
the target cell, which is transcribed into the DNA by the reverse transcriptase
that is also encoded by the virus. This DNA then forms a preintegration complex
with the accessory protein Vpr, the integrase and the protein matrix. These
proteins all contain localization sequences, allowing the preintegration complex
to cross the nuclear membrane. This is a specific feature of lentiviruses and
the reason why they can also infect non-dividing cells. Vectors based on other
viruses cannot enter the nucleus through its membrane, they have to wait until
the cell starts dividing and therefore the nuclear membrane is broken down in
order to get through to the host cell DNA [73]. When the vector DNA has
reached the host cell DNA, it is stably integrated via the enzyme integrase (see
Fig.10). Another feature of lentiviruses constituting an advantage over working
with other retroviral classes is the fact that they preferentially insert in introns
of chromosomal regions rich in expressed genes. Therefore chances are less that
they insert in an exon of a gene, disrupting its expression [13] [14].
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Figure 10: Lentiviral life cycle: Lentivirus based vectors (e.g. HIV) have the ability to infect
dividing as well as non-dividing cells. 1. The virus specifically binds via retroviral receptors
located on the surface on the host cell to its plasma membrane. 2. The viral lipid-layer
surrounding the viral nucleocapsid fuses with the host cell membrane and allows entry of the
virus via endocytosis (3.) 4. The viral genome is released into the cytoplasm along with the
two viral enzymes reverse transcriptase (RT) and the integrase. The vector RNA is transcribed
into DNA by the RT, which forms a preintegration complex with the accessory protein Vpr,
the enzyme integrase, and the protein matrix. These proteins contain localization sequences,
allowing the preintegration complex to cross the nuclear membrane [73. After entering the
nucleus the viral cDNA is stably integrated into the host genome by integrase as a pro-virus. 7.
The viral DNA is transcribed by the host cell machinery into new retroviral genomes (RNA). 8.
While some RNA molecules reside in the cytoplasm as they are, others are translated and viral
proteins are produced from them. These proteins help to assemble new viruses and package
the viral RNA molecules into nucleocapsids. 9. The virus buds from the cell, leaves it via
exocytosis taking along a lipid-bilayer envelope of plasmamebrane with viral proteins on its
surface. These proteins will again bind to new retroviral receptors on the next host cell. Since
the integration of the pro-virus into the host cell genome is stable, it is passed on to the
daughter cells also after cell division. Scheme by Hemminki et. al 2005 [73] [74].
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Structure of lentiviruses
Lentiviruses are around 80-100 nM in diameter. They enclose an RNA genome
in a lipid-bilayer enveloped nucleocapsid (see Fig. 11 and 12).
 
Figure 11: Electron microscopy picture of HIV budding from an infected host cell.
Picture from Wellcome images photolibrary, number B0005754.
The lentiviral genome comprises two linear positive-sense single stranded 8-12
kb stranded RNA molecules. Its basic structure is the same as the one of all
retroviruses: The genome is flanked on both sides by long terminal repeats (LTR).
These are short DNA sequences repeated up to thousands of times. The LTRs
mediate the integration of the retroviral DNA via an LTR specific integrase into
the host chromosome. The lentiviral genome contains three essential genes: gag
encodes a precursor protein of the viral structural proteins that is cleaved by a
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viral protease into the matrix (MA), capsid (CA) and nucleocapsid protein. pol
encodes three enzymes; a protease important in virion maturation, the reverse
transcriptase needed to convert the RNA molecules of the lentiviral genome into
insertable cDNA molecules and the integrase to insert the cDNA molecule into
the host genome as a pro-virus. Finally env encodes the envelope glycoprotein
that allows attaching of the virus to the host cell membrane and entry into the
cell.
 
Figure 12: Schematic representation of HIV virus morphology. Scheme by Shen group
Shang Hai Jiao Tong University.
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Lentiviral genomes are more complex than the ones of more simple retroviruses
(e.g. onco-retroviruses, see Fig. 13).
 
Figure 13: The retroviral genome structure: The onco-retroviral genome consists of three
genes, gag, pol and env encoding the structural proteins, the reverse transcriptase and integrase,
and envelope proteins respectively. The lentiviral genome contains additional genes encoding
for regulatory proteins (tat, rev) or accessory proteins (vif, vpr, vpu, nef ) that help the virus
enter the host cell and ensure a prolonged infection of the host cell. The psi (Ψ) element
found in both types of retroviruses is a packaging element and is involved in regulating the
encapsidation of the retroviral RNA [76]. Scheme by Hemminki et al. 2005 [74].
Lentiviruses have evolved better mechanisms to optimize all steps of infection.
Unlike onco-retroviruses, lentiviruses have additional accessory genes, e.g. in
the HIV-1 genome there are the vif, vpr, vpu, tat, rev and nef genes, encoding
proteins required for more efficient viral replication and maintenance of infection
in the target cell [75]. Herein, Tat is a positive regulator of transcription, while
Rev is responsible for export of spliced or partially spliced viral transcripts from
the nucleus (see Fig. 14).
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Figure 14: Summary of lentiviral genes and the function of their corresponding pro-
teins. Scheme from “The Immune system”, Garland Science 2005).
3.3.2 Lentiviral vector expression systems
Seven years after the discovery of HIV in 1983, a first HIV-based vector DNA
delivery system was described [76] [77]. These are replication-defective HIV-1
vector due to deleted envelope (env) protein sequences. They are co-transfected
with expression vectors that encode heterologous Env proteins from other viruses,
e.g. human T cell leukemia virus type I- HTLV-I Env protein yielding so-called
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HIV-1 pseudotypes (chimeric lentiviral vectors). These first gene delivery systems
have constantly been improved and also become safer. Since there would be a
potential of the viral RNA to recombine and a cross-species transmission could
take place, the vector systems of the first generation were further developed
including a deletion of almost all the accessory and regulatory genes and splitting
the vector genome into parts (several vector constructs). These measures reduce
the risk of vector recombination and mobilization to a minimum. The most
sophisticated vectors nowadays are third generation lentiviral vectors that are
based on HIV-vectors (see Fig. 15). Deletion of the env gene apparently still
allows formation of viral particles, however, they are non-infectious. The broad
variety of available env genes allows to pseudotype viruses with other envelope
glycoproteins, offering a wider range of target host cells to the virus [78].
3rd generation lentiviral vector systems:
The latest 3rd generation vector systems were developed based on the concept
of separating the cis-acting elements (essential for RNA synthesis, packaging,
reverse transcription and cDNA integration) from the trans-acting elements (viral
enzymes, structural and accessory proteins). These systems consist of a packaging
vector, a transfer vector and an envelope expression cassette (see Fig. 15. A-C).
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Figure 15: Vectors of lentivirus-based gene delivery systems: A–C: Packaging vectors,
transfer vectors and the envelope vector are the plasmids utilized for transient transfection
of a producer cell line (e.g. HEK 293T). A: Packaging vector plasmids: The original first-
generation vectors contained all regulatory and accessory viral genes expressed from CMV
promoter, while second-generation vectors encode only Tat and Rev proteins. The latest
third-generation packaging systems are split onto of two plasmids: one encoding Gag and
Gag-pol polyproteins, the second encoding the Rev protein. B: Transfer vector plasmids: In
non-SIN (self-inactivating) vectors, viral RNA is expressed from intact 5’ LTR. SIN vector
have a deletion in U3 region (∆U3), leading to an inactivation of the entire viral RNA after
pro-virus integration. C: Envelope vector. Depending on the glycoprotein encoded by the
vector, the virus is pseudotyped with different envelope proteins, enhancing the tropism of
the virus. D: Vector genomic RNA: Co-transfection of either second-generation packaging
vector or third-generation vectors in co-transfection with the SIN transfer vector and envelope
vector leads to formation of viral particles that contain dimeric RNA bearing ∆U3 mutation.
E: After stable provirus integration into host cell DNA, the transcription from the mutated 5’
LTR (duplicated 3’ ∆U3) is stopped. Abbreviations: CMV, cytomegalovirus immediate-early
promoter; EF1α, human elongation factor 1-α promoter; gag, 5’ portion of gag gene containing
dimerization/packaging signals; PBS, primer binding site; DIS, dimerization signal; SD, splice
donor site; SA, splice acceptor site; ψ, packaging signal; cPPT, central polypurine tract;
CTS, central termination sequence; RRE, Rev response element; PPT, polypurine tract; pA,
polyadenylation signal; ∆U3, SIN deletion in U3 region of 3’ LTR; P, internal promoter for
transgene expression; WPRE, woodchuck hepatitis virus (WHV) post-transcriptional regulatory
element. Figure by Pluta et al. 2009 [69].
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Packaging vector
All genes necessary for viral enzyme and structural protein expression for infectious
particle formation are found on this vector. The env gene is missing, as well as
the ones encoding the accessory proteins Vpu, Vpr, Nef and also the regulatory
proteins Rev and Tat which used to be included on the packaging plasmids
of the first generation of lentiviral vectors. Moreover, also the LTRs and ψ
packaging sequences were eliminated [79], preventing full-length mRNA encoding
trans elements from being packed into vector particles. RNA synthesis was
driven by other viral promoters, usually CMV (cytomegalovirus) or RSV (Rous
sarcoma virus) (instead of the LTRs), the polyA signal was taken from SV40
(simian virus) or the insulin gene. While tat is completely deleted on the
final 3rd generation packaging vector, rev was placed on another vector. The
function of Tat was substituted by modified 5’ LTR enhancer promoter elements,
which usually contain strong constitutive active RSV or CMV-derived promoters
[80]. Astonishingly, all these manipulations did not affect vector production or
infectivity much.
Transfer vector
This vector expresses full-length mRNA containing all cis-acting elements needed
for the packaging, reverse transcription, nuclear import and integration of the
cDNA into the host genome. Inserted in this vector is the transgene that should
be delivered to the host cell and be stably integrated for long-term overexpression.
This gene of interest is driven by an internal promoter, which usually resides
between the 3’ Tat/Rev SA site and the 3’ LTR (see Fig. 15 B). Earlier transfer
vectors still contained the tat sequence, Tat-independent transcription of the
vector cassette was achieved by replacing the enhancer/promoter sequences in
the 5’LTR with a strong promoter derived from CMV (see Fig. 15 B) [81]. These
transfer vectors are an essential part of the 3rd generation packaging systems
that lack Tat. Deleting the enhancer/promoter sequence in the 3’ LTR has led
to the creation of so-called self-inactivating (SIN) vectors (see Fig. 15 B [82] [83]
[84]. When infecting host cells with viruses made from these transfer constructs,
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this deletion is reproduced in the 5’ LTR during the reverse transcription which
leads to the transcriptional inactivation of the pro-virus (see Fig. 15 D, E). This
SIN design also reduces the expression of full length transcripts for packaging,
therefore the possibility of vector mobilization is minimized [85].
Envelope vector
The envelope vector is the third part of the 3rd generation lentiviral vector
systems. It encodes the envelope glycoproteins (see Fig. 15 C). Since the original
lentiviral env gene is deleted from the system, this additional vector expressing
a heterologous glycoprotein is used for the virus production. As mentioned
before, this technique is called pseudotyping, it increases the safety because the
sequence homology with wild-type virus is reduced. Furthermore this broadens
the tropism of the virus, a wider range of host cells can possibly be infected.
Finally pseudotyping enhances the stability of the virus particle, which allows
concentration with ultra-centrifugation and further long-term storage at very low
temperatures [76] [78]. The most commonly used glycoprotein nowadays is the
vesicular stomatitis virus-glycoprotein (VSV-G). Virions with this glycoprotein
show excellent stability and infect virtually all mammalian and insect cells. In
addition, the VSV-G facilitates virus entry via endocytosis, which reduces the
requirement for viral accessory proteins, still ensuring full virus infectivity [86]
[87]. So far, it remains unclear, which are the binding targets of the VSV-G on
the host cell membrane.
One disadvantage of the production of VSV-G pseudotyped viruses is, that it
can be toxic to some mammalian cells, if it is constitutively expressed [88]. The
solution to this problem was found in using producer cell lines like HEK293T
cells, which are transiently transfected with the 3 vectors (packaging, transfer
and envelope vectors). These viruses are then used to transduce the host cells,
but they will not be able to produce the virus themselves.
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3.3.3 Tetracycline inducible expression using lentiviral gene delivery
systems
Since one use of lentiviral gene delivery systems is the approach of gene therapy
of human diseases, it is important that the expression of the gene of interest
can be controlled within the host cell. Depending on what the protein is, it
might be toxic if expressed in high amounts. One solution to this problem is
the creation of tetracycline controlled lentiviral vector systems. These systems
are fully prokaryotic, they use components of the E. coli Tet-resistance operon
and are therefore not showing pleiotropic effects in eukaryotic host cells [89].
Tetracycline (tet) and its synthetic derivative Doxycycline (Dox) induce or inhibit
expression of the gene of interest by controlling its tet-responsive promoter. They
can be administered in the growth medium of cell in vitro or oral in vivo and are
able to penetrate all tissues, including passage of the blood brain barrier. The
Dox concentrations used to control gene expression are below the level of those
needed for bacteriostatic function. Additionally it has a relatively short half-life,
therefore gene expression responses are fast and can be reverted within short
time [90]. The Dox response is dose-dependent.
The first tet-controlled expression system was a so-called Tet-off system, in which
a Tet-controlled transactivator (tTA) binds the Tet-responsive element (TRE)
and induces gene expression in the absence of Tet or Dox [91]. The TRE is made
up of seven tandem copies of Tet operator (tetO) sequences and resides upstream
of the CMV minimal promoter (TRE/CMV). tTA is a chimeric protein consisting
of the bacterial Tet-repressor (tetR) fused to the HSV (herpes simplex virus)
VP16 transactivation domain.
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The Tet-on system uses a mutated version of the tTA, the reverse Tet-controlled
transactivator (rtTA). The rtTA binds the tetO sequences in the TRE and only
when Dox is administered the rtTA is sequestered away from the DNA allowing
the transcriptional enzymes to access the promoter and start gene transcription
(see Fig. 16) [92].
Both, the inducible transgene and the transactivator need to be present in the
same cell. This is made possible by lentiviral vector delivery. The first lentiviral
vectors used were Tet-off systems [94] [95] [96]. Up to 500-fold induction of
gene expression over background was observed, but the background levels in the
un-repressed state were unacceptably high. Another drawback of this system is,
that in a clinical setting, the patient must be under constant medication with
Dox, to not express the transgene at all times. To overcome this disadvantage, the
first lentiviral Tet-on systems were tested, continually optimized to finally lead
to the development of the Tet-on system using a fusion protein of rtTAKRAB
to suppress gene expression in the absence of Dox. The Krüppel-associated box
(KRAB) protein domain of human KOX1, is a Krüppeltype zinc finger factor
[97]. It is a transcriptional repression module, suppressing the polymerase II and
polymerase III mediated transcription stretching over a distance of 2-3kb from
its DNA binding site (see Fig. 17). This might be mediated via formation of
heterochromatin [98]. Therefore the repression of transcription mediated by the
fusion protein of KRAB with rtTA is not only drug dependent but also exerts its
effects on an additional epigenetic level.
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Figure 16: Doxycycline-regulated gene expression. Shown is a tet-off system, where the
chimeric tetracycline transactivator protein (tTA) consists of the TetR domain that recognizes
the tetO fused to the VP16 transactivating domain of herpes simplex virus. tTA binds to
seven tetO domains (tetO7) connected to a minimally active CMV promoter (CMV*), allowing
transcriptional induction of the gene of interest. Doxycycline binds the tTA and prevents gene
activation. In the tet-on system, TetR is mutated to rTetR (rtTA). Here the gene of interest
can only be transcribed if Dox is present in the system, so that it can bind to the tetO7 and
activate gene expression. Scheme by Kafri et al. 2000 [93].
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Figure 17: Lentiviral vector construct expressing the Dox-responsive fusion protein
tTR-KRAB and dsRed II as a fluorescence marker. Scheme by Wiznerowicz et. al 2003.
[99]
In the lentiviral vector system developed by Trono et al. (Lausanne, Switzerland),
the rtTA (or herein tTR: tet-Trans-Repressor) fused to the KRAB protein is
expressed on one vector, while the gene of interest is on another transfer vector,
also containing the TRE (pLV-T, unpublished vector).
The KRABtTR fusion protein is expressed from the ubiquitously active EF1-α
promoter as part of a bicistronic transcript (that also produces the dsRed II
marker) and modulates transcription from an integrated promoter that is next
to the tet operator (tetO) sequences. Both the gene of interest and the tetO
are on a second vector called pLV-T (unpublished vector, also see methods
section 4.2.). When both vectors are delivered to the host cell, the tTR-KRAB
fusion protein inhibits expression of the marker gene in the absence of Dox by
binding to the tetO sequences upstream of the maker gene. Cells that express
the transrepressor should have a red fluorescence (ds RedII). Adding Dox to the
cell medium allows binding of the drug to the tTR portion of the transcriptional
repressor, sequestering it away from the DNA and allowing the transcription
machinery to access the promoter [99] (See Fig. 18, depicted is the one vector
system, where tTR-KRAB and the gene of interest are on the same vector).
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Figure 18: Mechanism of Doxycycline inducible expression of a target gene. Shown is
the one vector system, where both tTR-KRAB and the marker gene lie on one vector only. (A)
In the absence of DOX, tTR-KRAB binds to the tetO and suppresses transcription of a target
gene (Marker) (B) In the presence of DOX, tTR-KRAB cannot bind to the tetO, allowing
transcription and expression of the target gene [99]. H1: human H1 promoter (mtDNA), tetO:
Tet: Operator, SIN: self-inactivation domain, EF-1α: ubiquitously active elongation factor 1-α
promoter. WPRE: Woodchuck hepatitis virus posttranscriptional regulatory element: enhancer
of transcription of the marker gene in the host cell. Scheme taken from Wiznerowicz et. al
2003 [99].
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4 Materials and methods
4.1 Cell lines
mpkCCDCl14 is an immortalized mouse cortical collecting duct cell line that was
originally described by Bens et al. in 1999 [100]. For maintenance of the culture
and for lentiviral transductions, cells were seeded into plastic dishes (Corning
Costar) in standard medium (DMEM:Ham’s F12 without phenolred, 1:1 vol/vol
Invitrogen; 60 nM Na+-selenate, 5 mg/ml Apo-Transferrine, 2 mM glutamine, 50
nM dexamethasone, 1 nM triiodothyronine, 10 ng/ml epidermal growth factor, 5
mg/ml insulin, 20 mM D-Glucose, 2% fetal calf serum (FCS Amimed #2-01F10-I,
Lot A127772P, Bioconcept, Allschwil, Switzerland) and 20 mM Hepes pH 7.4)
and incubated at 37°C in 5% CO2 / 95% air. For fluorescence stainings, western
blot analysis and electrophysiological experiments in Ussing chamber, cells were
cultured on 12 mm diameter snapwell permeable filter supports (polycarbonate
membrane, Corning Costar #3107) for 5 days in standard medium, 5 days in
filter medium (standard medium without FCS, Apo-Transferrine and EGF) and
starved 1 day in DMEM: Ham’s F12 1:1 vol/vol only.
mCCDCl1 cells were originally described by Gaeggeler et al. [101]. They are
another immortalized mouse kidney cortical collecting duct cell line. Unlinke
the mpkCCDCl14 cells, the mCCDCl1 cells do express the mineralocorticoid
receptor. We obtained mCCDCl1 cells as well as a newer clone 6 from the
lab of Prof. Dr. Olivier Staub in Lausanne. The mCCDCl6 has shown more
stable properties in terms of transepithelial transport measurements over several
passages compared to its predecessor clone 1. They were grown 5 days in complete
medium DMEM/Ham’s F12 (1:1 vol/vol) (Invitrogen, Switzerland), 5 mg/ml
insulin, 5 mg/ml Apo-Transferrine, EGF 10 ng/ml, 60 nM Na+-selenate, 1 nM
triiodothyronine, 50 nM dexamethasone at 37°C/5% CO2, then 5 days in filter
medium (same as complete medium except 3 nM dexamethasone and no EGF,
Apo-Transferrine and FCS). Cells were starved overnight in minimal medium
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(DMEM F12 (1:1 vol/vol) only) and then used for the experiments.
Human embryonic kidney cells (HEK293T) were kindly provided by the lab of
Prof. Dr. Daniel Schümperli, University of Berne and grown in plastic culture
dishes (Corning Costar) in DMEM (Invitrogen Cat no. 41965-039), 10% FCS
(heat inactivated), 1% NEAA and 4 mM L-glutamine at 37°C / 5% CO2.
4.2 Cloning of ATF3 into lentiviral constructs and lentiviral transduction
of mpkCCDCl14 cell lines
Mouse total kidney RNA was isolated with the Qiagen RNeasy Mini Kit, according
to the manufacturer’s protocol (Qiagen, Hombrechtikon, Switzerland). Reverse
transcription was performed with oligo dT primers using the TaqMan Reverse
Transcription Kit (Applied Biosystems, Foster City, USA). cDNA of ATF3 was
amplified by PCR using 2.5 U of a proof reading polymerase (Pfu) (Promega,
Madison, USA), 1x Pfu-reaction buffer (Promega), 2 mM dNTPs, 0.5 µM 5’-
forward-primer, 0.5 µM 3’-reverse-primer for 35 cycles (5 min 95°C, then cycles:
30 sec 95°C, 30 sec 64°C, 2 min 68°C, then finishing with 10 min 68°C, o/n 4°C).
Primers for cloning ATF3 were designed to contain restriction enzyme sites for
subsequent digestion of PCR product and vector for ligation.
Primers:
ATF3 fwd with BamHI restriction site: 5 - AAA AGG ATC CTG GAG CCA
ATC GGC TAA C - 3’
ATF3 rev with XmaI restriction site: 5’ - AAA CCC GGG GAG TGG GAC
AAT GCA GTA GG - 3’
The ATF3 PCR-product was cloned into the pLV-T vector, containing a Tet
operator (tetO) (unpublished vector). All vectors needed to produce lentiviruses
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of this Tet-on system were obtained from the Tronolab EPFL Lausanne [99].
Briefly, this inducible overexpression system relies on a tetracycline-controlled
hybrid protein called tTR-KRAB. tTR is the tetracycline repressor with a DNA
binding domain from Escherichia coli Tn10 which is fused to the human KRAB
domain which is an epigenetic transcriptional repressor (see Fig. 19).
Figure 19: The lentiviral Tet-On vector system from the Tronolab, EPFL Lausanne:
The KRABtTR fusion protein is expressed from the ubiquitously active EF1-α promoter as part
of a bicistronic transcript (that also produces the dsRed marker) and modulates transcription
from an integrated promoter that is next to the tet operator (tetO) sequences. ATF3 was cloned
downstream of the tetO. Two lentiviruses based on the human immunodeficiency virus type 1
were used as delivery vehicles for the two vectors (pLVCT-tTRKRAB-dsRed and pLV-T-ATF3).
When cells were grown with no Dox in the medium, ATF3 expression was suppressed. Upon
addition of 1 mg/ml Dox to the cell culture medium, the tTR binds the Dox and is sequestered
away from the promoter, ATF3 or a GFP control are expressed within 3 days (see Fig. 18).
Figure modified from Wiznerowicz et. al 2003 [99].
Protocol of virus production:
All vectors needed for the following lentivirus production protocol were con-
structed in the Tronolab (Prof. Dr. Daniel Trono, EPFL Lausanne) and obtained
either via Addgene (www.addgene.org) or in the case of pLV-T from the Lab of
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Prof. Dr. Schümperli, University of Berne. The vectors were amplified using
HB101 E.coli cells for subsequent Maxipreps of the constructs (with Qiagen
Maxi Kit, Endonuclease free Cat.no. 12362l). Human embryonic kidney cells
(HEK293T) were grown in DMEM with 10% fetal calf serum, 1% NEAA and
4 mM L-glutamine seeded at 6 x 106 cells per 10 cm dish. On the following
day, they were co-transfected with the packaging plasmid pMDG.2 (5 µg), the
envelope plasmid pCMV∆R8.91 (10 µg) and the vector with the gene of interest
either, pLV-T ATF3, pLV-T-EGFP or pLVCT-tTRKRAB-dsRed (15 µg) using
the calcium phosphate DNA precipitation method. Corresponding amounts of
plasmids were mixed and volume was added up to 450 µl with 0.1 TE pH 8.8,
add 50 µl of CaCl2 and 500 µl of 2x HBS, mixed well and let complex for 20
min at room temperature. The precipitates were added dropwise to the cells and
cells incubated with the virus overnight at 37°C / 5% CO2. The medium was
changed the next day and left on the cells for 3 days. On the second day the
target cells, in this case mpkCCDCl14 were seeded at 1x105 cells into 6-well plates.
On the third day the virus supernatant of the HEK293T cells was centrifuged at
1000 rpm for 5 min at 4°C, then filtered through a 0.22 µm filter and polybrene
was added to a final concentration of 4 µg/well. 1 ml of virus was applied to
the mpkCCDCl14 cells and 1 ml of mpkCCD complete medium was added. Cells
were incubated overnight at 37°C / 5% CO2. The next day the medium was
completely replaced with mpkCCD complete medium.
mpkCCDCl14 cells were first transduced with the pLVCT-tTRKRAB vector and
checked for red fluorescence. Subsequently a second virus transduction with the
pLV-TATF3 or as a control pLV-T-EGFP construct was performed. These cells
were then subjected to limiting dilution in 96-well plates, where cells were seeded
at very low density of 0.5 cells, 1 cell or 2 cells per well. These clones were
observed for 2 weeks; wells with only 1 cell population growing were selected and
transferred to bigger growth areas. Finally, the clones were functionally tested
for their inducible and long-term stable expression of ATF3 or GFP.
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4.3 Western blot of ATF3 overexpressing mpkCCDCl14 cells
mpkCCDCl14 ATF3/KRAB transduced cells were grown in 6-well plastic plates
and harvested after 3 days of 1 mg/ml Doxycycline induction. 100 µl RIPA
buffer (150 mM NaCl, 1% Igepal (NP40), 0.5% DOC, 0.1% SDS, 50 mM Tris pH
7.5, protease inhibitor cocktail PIC, Sigma) by scraping them off the plastic and
sonicating the samples for 30 seconds. Cell debris was pelleted with centrifugation
at 100 x g for 10 min. Protein concentration of the samples was determined
using the Bradford protein assay (Biorad 500-0113, 500-0114, 500-0115) to
ensure equal protein amount loading. Samples were diluted in 4x loading buffer
(4x SDS 8%, Tris-HCl 200 mM pH 6.8, 40% Glycerol, 0.4% Bromphenolblue)
with 10% β-Mercaptoethanol. 20-40 µg were loaded on a 12% polyacrylamide
gel, separated by SDS-PAGE and electrophoretically transferred to a PVDF-
membrane (Immobilon-P, Millipore, USA). After blocking with 5% low-fat milk
powder in Tris buffered saline / 0.1%-Triton (TBS-T) for 1 h at room temperature,
the blots were incubated with primary antibodies rabbit-anti-mouse ATF3 (ATF3
C-19, sc-188 rabbit polyclonal IgG, Santa Cruz) diluted 1:500 in 2.5% milk-TBS-T
over night (o/n) at 4°C. After washing the blot with TBS-T, it was incubated
with secondary antibody diluted 1:1000 (donkey-anti rabbit conjugated with
horseradish peroxidase, BD transduction laboratories, Franklin Lakes, USA) in
2.5% milk-TBS-T for 1 h at room temperature. Antibody binding was detected
with the Immobilon Western Chemiluminescent HRP Substrate (Millipore, USA)
and visualized with a DIANA III camera (Raytest, Straubenhardt, Germany).
Images were further processed using Photoshop 7 (Adobe, San Jose, USA).
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4.4 Immunofluorescence staining of ATF3 overexpressing mpkCCDCl14
cells
mpkCCDCl14 ATF3/KRAB transduced cells were grown on glass coverslips and
stained after 3 days of 1 µg/ml Dox induction. Cells were washed with PBS
and fixed with 3% paraformaldehyde (PFA). After 15 min of blocking with 2%
BSA / 0.2% Triton-X100, cells were incubated at 4°C o/n with primary antibody
against ATF3 diluted 1:500 in 2% BSA / 0.2% Triton-X100. After washing, cells
were incubated 1 h at room temperature with conjugated secondary antibody
(Alexa Fluor 488 goat-anti-rabbit IgG, Invitrogen, USA) diluted 1:1000 in 2%
BSA/0.2% Triton-X100. Images were acquired using the Nikon Eclipse TE3000
inverted fluorescence microscope (Nikon AG Küsnacht, Switzerland) equipped
with a DS-5M Standard CCD camera (Nikon) and the NIS-Elements software
(Nikon). Images were further processed using Photoshop 7 (Adobe, San Jose,
USA).
4.5 Transepithelial electrophysiological measurements
The transepithelial electrical resistance across intact monolayers of mpkCCDCl14
WT or ATF3 transduced cells grown on permeable filter membranes was measured
using an EVOHM device (World Precision Instruments, Sarasota, Florida, USA).
A transepithelial resistance of >1 kΩ was considered as a perquisite for using
the filter cultures for subsequent electrophysiological measurements in an Ussing
chamber set-up [102] [103]. 200’000 cells per filter (1 cm2 area) were grown
for 11 day as mentioned earlier (see 4.1.). On the day of the experiment,
filters were carefully mounted in a multichannel current clamp device of an
Ussing chamber (Model VCC MCC Revision B, Physiological Instruments) and
monolayers maintained under current clamp conditions at a DC clamp level of
0 µA. Bipolar pulses of 5 µA lasting 620 ms were given every 60 sec. Cells
were allowed to equilibrate to the given circumstances in the chamber (37°C,
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continuous bubbling with 5% CO2 / 95% O2 bubbling to maintain stable pH)
for 1 hour. Aldosterone was then applied to the media in the chamber (300 mM
- 1 µM) currents were further traced for 2 hours. After this, optionally 10 nM
arginine-vasopressin (AVP) was added to the medium and currents were traced
for another 30 min. To finish, Na+ currents mediated via ENaC were specifically
blocked using 10 µM amiloride.
 
Figure 20: Original transepithelial current trace using an Ussing chamber system:
mpkCCDCl14 cells were grown on permeable filter membranes and treated with aldosterone
300 µM (red) in the Ussing chamber set-up. After 150 min amiloride (10 nM) was added to
the medium in the chambers to block ENaC mediated current. In parallel, another filter with
cells was mounted and treated with the vehicle as control (black). Amiloride sensitive current
(Iamil) is significantly higher in aldosterone treated cells. This trace is missing the optional
AVP addition after aldosterone incubation. Figure taken from PhD Thesis of Dr. Gabriele
Adam. [104].
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4.6 Western blot of MAPK p38, JNK/SAPK1 and ERK1/2
mCCDCl6 cells were grown on filter supports as described in 4.1. To check for
MAPK phosphorylation induced by a medium change the cells were serum and
growth factor starved overnight. Then the cells underwent different medium
changes: (1) A mock change, where the medium was aspirated and the same
medium was added back to the cells immediately, (2) a medium change where
the old medium was replaced by fresh minimal medium that was pre-warmed
in a tube, (3) a medium change where the old medium was replaced by fresh
medium that was CO2-equilibrated and pre-warmed in the incubator, and (4) a
conditioned medium change where the medium was taken from one well of cells
and put onto another. All cells were lysed seven min after the medium change
took place. The lysis buffer contained 10 mM Tris in HCl pH 7.4, 1% SDS, 1x
protease Inhibitor Cocktail (Sigma), 1 mM Na Orthovanadate and 1x Phosstop
(Roche) to stop dephosphorylation of the proteins. Samples were sonicated, 4x
Laemmli buffer with 10% β-Mercaptoethanol added and cooked for 3 min at
95 °C. Approximately 5 µg were loaded on a 10% SDS-Polyacrylamidgel and
transferred onto a PVDF membrane after running the gel. For the transfer
a semi-dry blotter was used to ensure equal transfer also on the sides of the
membrane. Transfer was 45 min at 25 V. The total- and phosphospecific mouse
antibodies against JNK/SAPK1, p38 and ERK1/2 were from the MAPK sampler
kit (BD Pharmingen 612544):
 
Table 2: Table taken from Technical Data Sheet MAPK sampler Kit 612544 BD Pharmingen.
Membranes where phosphospecific antibodies were used to detect the MAPK were
blocked with 2% Topblock in TBS-0.1% Triton for 1h, while membranes for total
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MAPK detection were blocked with 5% non-fat dry milk in TBS-0.1% Triton.
Antibodies were diluted according to the table above either in 1% Topblock in
TBS-0.1% Tween for the phosphospecific antibodies or in 2.5% non-fat dry milk
in TBS-0.1% Tween. All primary antibodies were incubated overnight at 4°C.
Secondary anti-mouse AP antibody was diluted 1:5000, incubated at RT for
1 h and developed with AP chemiluminescence substrate (Millipore Cat. No.
WBKDS0100). For actin detection, membranes were washed thoroughly with
TBS-Tween 0.1%, stripped with a low pH stripping buffer (1% SDS/Glycine, pH
2) for 10 min, washed again and incubated with anti-mouse-β-actin antibody
1:5000 (Sigma) in 2.5% non-fat dry milk in TBS-0.1% Tween at RT for 1h.
Secondary anti-mouse-HRP antibody 1:5000 was diluted in 2.5% non-fat dry milk
in TBS-0.1% Tween and applied for 1h RT. Membranes were developed using
HRP chemiluminescence substrate (Millipore Cat. No. WBKLS0500).
4.7 ATF3 knockout mouse
The ATF3 knockout mouse (C57BL/6 background) was kindly provided by Prof.
Dr. Tsonwin Hai, USA [105]. Wildtype C57BL/6 (Harlan Animal Laboratories,
Holland), and ATF3 knockout mice were housed in standard conditions and fed
a standard diet. Pups from ATF3 knockout breedings were weaned at 28 days as
opposed to the common weaning of wildtype mice after 21 days (T. Hai, personnel
communication). All procedures for mouse handling and housing were conducted
according to the Swiss Animal Welfare laws and approved by the Kantonales
Veterinäramt Zürich.
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ATF3 knockout mouse genotyping
The genotyping protocol was obtained from the lab of Prof. Dr. Tsonwin Hai.
Primers:
# 186 AGA GCT TCA GCA ATG GTT TGC
# 187 TGA AGA AGG TAA ACA CAC CGT G
# 188 ATC AGC AGC CTC TGT TCC AC
Primers (100 µM) were mixed in a ratio of 10:5:5 of #186, #187, and #188
respectively. 2 µl template mouse tail DNA was mixed with 2 µl 10x Eurobio
Taq buffer, 1 µl MgCl2 (25 mM), 0.4 µl dNTPs 2 µl primer mix, 9.6 µl mili-Q H2
and 1 µl Eurobio Taq for 1 PCR reaction. PCR program: 1. 94°C 4min, 2. 94°C
30 sec, 3. 57°C 30 sec, 4. 72°C 30 sec, 5. 72°C 10 min, 4°C o/n. The wildtype
band: 329 bp, knockout band: 236 bp.
4.8 B1EGFP mouse
The B1EGFP mixed background mouse (C57BL/6 x CBA) specifically expresses
EGFP under the promoter of the V-ATPase B1 subunit. Therefore EGFP is
specifically expressed in tissues expressing V-ATPase, namely the kidney, the
male reproductive tract, and the lung (nonciliated airway cells). In the kidney
tubule EGFP is specifically expressed in intercalated cells of the collecting duct
and connecting tubule [106]. This allows sorting of green fluorescent tubules
with COPAS (complex object parametric analyzer and sorter, see 4.12.) and
subsequent RNA and protein extraction from the tubule material (see Unionbio
webpage for COPAS).
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B1EGFP mouse genotyping
Primers:
Fw B1-EGFP 5‘ - CCC TCT TCC CTT CTC CCT CCA - 3‘
Rev B1-EGFP 5‘ - CGC TGA ACT TGT GGC CGT TT - 3‘
The PCR reaction of 25 µl final volume was composed as follows: 2.5 µl 10x PCR
Buffer with MgCl2 (Sigma), 1.0 µl 10 mM dNTP Mix, 0.75 µl 10 µM fwd primer,
0.75 µl 10 µM rev primer, 0.2 µl Taq Polymerase 5 U/µl (Sigma D1806), 17.8 µl
H2 and 2 µl of genomic DNA extracted from mouse tails. Expected amplicon
size: 366 bp.
PCR Cycling Conditions:
1. 94°C 5 min; 2. 94°C 30 sec; 3. 65°C 30 sec; 4. 72°C 1 min ; back to step 2
for 10 cycles, 5. 95°C 30 sec; 6. 60°C 30 sec; 7. 72°C 1 min 45 sec; back to step
5 for 10 cycles; 8. 95°C 30 sec; 9. 55°C 30 sec; 10. 72°C 1 min 45 sec; back to
step 8 for 30 cycles; 11. 72°C 5 min; 12. 4°C pause. The B1EGFP WT mouse
was further bred with the ATF3 KO mouse to generate the ATF3 KO B1EGFP
mouse. This mouse is a complete ATF3 knockout, the GFP expression allows to
analyze the effect of ATF3 lack specifically on gene expression in the CNT/CCD
(see section 4.12. COPAS).
4.9 Metabolic cages
11-week-old wildtype C57BL/6 mice and ATF3 knockout mice were adapted to
metabolic cages (Tecniplast, Buguggiate, Italy) for two times two days with breaks
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in normal cages in between (see Fig. 21). Animals had free access to standard
mouse diet (18.5% crude protein, Kliba-Nafag, Kaiseraugst, Switzerland) and
drinking water. Daily food/water intake, urine/feces output and body weights
were measured.
 
Figure 21: Protocol of metabolic cage experiment comparing ATF3 KO mice to
wildtype mice.
4.10 Mouse perfusion
Mice were anesthetized either with isofluorane or via i.p. injection with ketamine
(90 mg/kg body weight, Narketan 10, Vétoquinol, Lure, France) and xylazine (10
mg/kg body weight, Xylazin, Streuli, Uznach, Switzerland) and perfused through
the left cardiac ventricle with phosphate buffered saline (PBS, pH 7.4) followed
by a buffered paraformaldehyde solution (4%, pH7) as previously described [107].
The kidneys were then harvested, the capsule was removed and the organs were
snapfrozen in liquid nitrogen for subsequent RNA or protein extraction.
4.11 Real-Time RT-PCR
100 ng of total RNA extracted with the RNeasy Kit (Qiagen) either from mouse
kidney, brain, heart, colon mucosa cells (from mice perfused with PBS, see
above section 4.9.), mCCDCl6 cell cultures or extracted with the RNAequous kit
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(Ambion) for COPAS sorted kidney tubules were used for reverse transcription
using the TaqMan® Reverse Transcription Kit (Applied Biosystems). Real-time
PCR was performed using the SYBR®Green JumpStart™ Taq ReadyMix™
(SIGMA) with 1 ng (for COPAS study see Methods 4.11.) or 2 ng (for whole
organ and cell culture specific expression studies) of cDNA per reaction.
Primers:
Mouse ATF3 fwd 5’ - AGA CCC CTG GAG ATG TCA GTC A - 3’
Mouse ATF3 rev 5’ - CGC CTC CTT TTC CTC TCA TCT T - 3’
Mouse SGK1 fwd 5’ - GAG GGA GCG CTG CTT CCT - 3’
Mouse SGK1 rev 5’ - GCA GAT AGC CCA GGG CAC T - 3’
Mouse ATF4 fwd 5’ - CTC GGC CCA AAC CTT ATG - 3’
Mouse ATF4 rev 5’ - CTT CTA TCA GGT CTT TCA GAT ACT - 3’
Mouse CHOP10 fwd 5’ - AGC TGG AAG CCT GGT ATG AGG - 3’
Mouse CHOP10 rev 5’ - AGC TGG AAG CCT GGT ATG AGG - 3’
Mouse αENac fwd 5’ - GGT GCA CGG GGA TGA G - 3’
Mouse αENac fwd 5’ - TAG TTG CCT CCG AGG CTT TC - 3’
Mouse NaPi2a fwd 5’ - TGA TCA CCA GCA TTG CCG - 3’
Mouse NaPi2a rev 5’ - GTG TTT GCA AGC TGC CCG - 3’
Mouse AQP2 fwd 5’ - TGG TGC TGT GCA TCT TTTG CCT - 3’
Mouse AQP2 rev 5’ - ACT TGC CAG TGA CAA CTG CTG - 3’
Mouse NCC fwd 5’ - ACA TCT GCT GGA AGG TGG AC - 3’
Mouse NCC rev 5’ - TGA CCT GCA TTC ATT CCT CA - 3’
Mouse HPRT fwd 5’ - TTA TCA GAC TGA AGA GCT ACT GTA ATG ATC - 3’
Mouse HPRT rev 5’ - TTA CCA GTG TCA ATT ATA TCT TCA ACA ATC - 3’
Mouse β-Actin fwd 5’ - CCA CCG ATC CAC ACA GAG - 3’
Mouse β-Actin rev 5’ - GAC AGG ATG CAG AAG GAG - 3’
PCR cycling protocol:
1. 95° C 2 min; 2. 95°C 3 sec, 60 °C 30 sec, repeat 40 times; 3. Dissociation
curve step: 95°C 15 sec, 60°C 1 min, 95°C 15 sec, 60 °C 15 sec
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The expression of the mRNA of genes of interest was calculated relative to
Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) or β-Actin as reference
genes. Relative expression ratios were estimated as R = (2(Ct(reference) – Ct(test)).
Ct: cycle number at the threshold, test : tested mRNAs (e.g. ATF3).
4.12 COPAS
As described in 4.8. we used WT B1EGFP mice to sort green fluorescent
CNT/CCD tubules to analyze gene expression in these kidney segments (referred
to as the ASDN). 2 groups of mice were analyzed: 4 non-injected WT B1EGFP
C57BL/6 mice (1 female, 3 males) versus 4 WT B1EGFP mice (2 females, 2 males)
that were injected for 1 h with 0.9%Na-Cl / 0.3% EtOH-injected. Additionally
we also sorted green fluorescent tubules of 4 non-injected ATF3 KO B1EGFP
C57BL/6 mice (2 females, 2 males), to see if a lack of ATF3 might make a
difference on upstream and downstream factors when compared to the WT
mice.
Mice were perfused through the left cardiac ventricle first with 10 ml PBS (room
temperature) and afterwards with 10 ml of a mix containing 1 mg / 10 ml
DNAse I (Sigma DN25), 10 mg /10 ml Collagenase Type-1 (Worthington 4196)
and 10 mg / 10 ml Hyaluronidase (Sigma H3884) in cold KREBS buffer. The
kidneys were removed from the mice and the cortex was dissected with razor
blades for further processing. The cortex was minced with the razorblade and
digested for 10 min, 5 min and finally 2 min in 10 ml of the digestion enzyme
mix at 37°C with vortexing in between the incubation times. Afterwards the
digestion mix was sieved through a 212 µm and a 250 µm sieve (coated with
5% BSA-KREBS), then filtered through a 100 µm nylon filter (Cell restrainer,
BD Falcon 352340) and a 40 µm filter (Cell restrainer, BD Falcon 252360). The
remains left on the 40 µm nylon filters were flushed off with cold KREBS buffer
and diluted to yield 50 ml of sorting material. From this tubule suspension, a
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green fluorescent fraction of tubules, a GFP-negative selected fraction (whole
kidney cortex without CNT/CCD) and a fraction containing the whole kidney
cortex were sorted using a COPAS (complex object parametric analyzer and
sorter, Unionbio). 800 tubules per tube were sorted, for each mouse between 2400
and 4000 tubules of the different kidney fractions were sorted. To sort one sample
cup of tubule suspension it took between 5-8 min. During this time the sample
was not cooled. The tubule suspension and the samples that were already sorted
were kept on ice. Sorting the tubules of 2 kidneys from each mouse took about 8
h. The samples were kept on ice during the sort and centrifuged at 800 rcf for 5
min at 4°C to pellet the tubules. 800 tubules per sample were lysed either in 50 µl
of RNA lysis buffer from the RNAequous micro kit (Ambion, Cat. No. AM1931)
or 20 µl of protein lysis buffer (10 mM Tris in HCl pH 7.4, 1% SDS, 1x protease
Inhibitor Cocktail (Sigma), 1 mM Na Orthovanadate with 1x Laemmli buffer,
and 10% β-Mercaptoethanol. 400 tubules per lane were used for Western Blot.
ATF3 was detected using the polyclonal antibody mentioned in 4.4. AQP2 was
detected using a polyclonal rabbit antibody (kindly provided by Prof. Johannes
Loffing) 1:5000 in 2.5% milk-TBS-Triton. Total RNA of the tubules lysed in
RNA lysis buffer was extracted using the Ambion RNAequous micro RNA kit,
yielding 20 µl of RNA per sample. Total RNA was reverse transcribed and qPCR
was performed following the procedure described in section 4.11. To ensure that
the green fluorescent tubules sorted were truly CNT/CCD, qPCR was performed
for NaPi2a (proximal tubule), NCC (TAL), AQP2 (CCD), ?ENaC (CCD) and
SGK1 (mostly ASDN). Gene expression in GFP-positive sorted fractions was
compared to GFP-negative sorted fractions (whole kidney cortex without the
green fluorescent tubules) and whole kidney cortex fraction of all mice. Also
the relative mRNA expression of ATF4 (upstream of ATF3), ATF3 and CHOP
(downstream of ATF3) was analyzed in all 3 fractions sorted for the 3 groups of
mice (WT B1EGFP non-injected, WT B1EGFP injected 1 h 0.9% NaCl / 0.3%
EtOH and ATF3 KO B1EGFP non-injected).
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KREBS buffer
Powder for 1 l for 2 l for 5 l
NaCl (58.5 g/mol) 145 mM 8.45 g 13 g 42.5 g
HEPES (238.3 g/mol) 10 mM 2.38 g 4.8 g 11.9 g
KCl (74.5 g/mol) 5 mM 0.37 g 0.75 g 1.86 g
NaH2PO4*1 H2O(138 g/mol) 1 mM 0.14 g 0.28 g 0.69 g
CaCl2 (147 g/mol) 2.5 mM) 0.37 g) 0.74 g) 1.84 g
MgSO4 (246.5 g/mol) 1.8 mM 0.44 g 0.89 g 2.22 g
Glucose (180.1 g/mol) 5 mM 0.9 g 1.8 g 4.5 g
All chemicals used for KREBS buffer obtained from Sigma Aldrich.
4.13 Statistics
Data were expressed as means ± standard error of the mean (SEM). Calculations
were carried out with Microsoft Excel, while the graphs were created using
GraphPad Prism™ Version 5.0 (GraphPad Inc.). Significance was tested with
GraphPad Prism™ using students T-Test unpaired) or one-way ANOVA, as
indicated. Statistical significance was accepted at P < 0.05.
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5.1 Regulation and impact of ATF3 expression in kidney CCD cell lines
5.1.1 Aldosterone stimulates ATF3 expression in mpkCCDCl14 cells
As mentioned in the introduction, this project was originally a continuation of
another study (by Fakitsas et al.) that showed that an aldosterone injection
strongly upregulates ATF3 on mRNA level within 1 hour in WT mice. Therefore
an in vitro model was created to study the role of ATF3 in the action of aldosterone,
on principal cells of the cortical collecting duct of the kidney. For this model
the mouse kidney cortical collecting duct cell line mpkCCDCl14 was used. Even
though this principal cell line does not express the mineralocorticoid receptor (MR,
aldosterone receptor), aldosterone can exert its effects through the glucocorticoid
receptor (GR), although significantly higher doses are required to do so [101].
To investigate whether the ATF3 mRNA induction seen in vivo in aldosterone-
injected mice can be reproduced in vitro in mpkCCDCl14, a former collaborator
(Dr. Gabriele Adam) had analyzed ATF3 mRNA levels in mpkCCDCl14 cells
upon treatment with 1 µM aldosterone over a timecourse of 3 h. Similar to the
response in mice, also cortical collecting duct kidney cells upregulated ATF3
mRNA expression in vitro upon aldosterone treatment with a peak after 1 h. After
this point of time, ATF3 mRNA levels decreased back to almost baseline levels
after 3 h (see Fig. 22). Thus, ATF3 appeared to be an early aldosterone-induced
gene in mpkCCDCl14 cells in vitro.
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ATF3 expression in mpkCCDCl14 cells treated with 1 µM aldosterone
 
Figure 22: Aldosterone upregulates ATF3 mRNA levels in mpkCCDCl14 cells: Cells were
cultured with 1 µM aldosterone over a timecourse up to 3 hours. Subsequent qPCR analysis
showed an approximately 8-fold upregulation of ATF3 mRNA levels after 1 h of hormone
treatment. After 3 h ATF3 mRNA levels were almost back to baseline. Errorbars: SEM. Graph
by Dr. Gabriele Adam, unpublished data.
Since the same effect was observed in vitro as was the case in vivo, namely that
ATF3 expression was stimulated by aldosterone also in the mpkCCDCl14 cells,
it was decided to use this cell line as a system to create a cell line which shows
inducible overexpression of ATF3 using lentiviral vector systems.
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5.1.2 Overexpression of ATF3 in a mixed population of mpkCCDCl14 cells
using a lentiviral Tet-On system
The ATF3 coding sequence was cloned into the pLV-T vector of a lentiviral two-
vector system (see methods section 4.2.). Both the pLV-T vector with ATF3 under
the control of a tet operator (tetO) and the vector expressing the tet-responsive
transrepressor (tTR) fused to a KRAB protein were transduced sequentially
into the mouse cortical collecting duct cell line mpkCCDCl14. Overexpression
of ATF3 was induced with 1 µg/ml Dox for 3 days. Western blot analysis of
the ATF3/KRAB mpkCCDCl14 mixed cell population showed a clear induction
of ATF3 expression at the expected band size level (approximately 23 kD) as
opposed to WT mpkCCDCl14 cells or GFP/KRAB mpkCCDCl14. However, also
the two control cell lines as well as un-induced ATF3/KRAB mpkCCDCl14 showed
a weak band at the same level that probably corresponds to endogenous baseline
levels of ATF3 expression, as well as unspecific bands in the lower kD range (see
Fig. 23).
 
Figure 23: Dox-induced overexpression of ATF3 in a mixed population of mpkCCDCl14
cells: WT mpkCCDCl14 cells were transduced with the tTRKRAB fusionprotein lentiviral vector
pLVCT-tTRKRAB and the pLV-T vector expressing ATF3 under the control of the tetO. Cells
were grown for 3 days in medium containing 1 µg/ml Dox (+) or without the antibiotic (-).
As controls WT mpkCCDCl14 cells and cells expressing inducible GFP were used. A clear
overexpression of ATF3 (ca. 23 kD) was seen after 3 days of induction with Dox in this Western
Blot. All cell lines used express low endogenous levels of ATF3.
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The Dox-inducible ATF3 overexpression could also be confirmed with immunoflu-
orescence of mixed populations of mpkCCDCl14 cells expressing KRAB and ATF3
(green). In WT mpkCCDCl14 cells, the endogenous ATF3 expression was below
the detection limit of the antibody in immunofluorescence (as opposed to the
Western blot, see Fig. 23). This was also not altered by the treatment with Dox.
ATF3/KRAB transduced cells showed a low level of ATF3 expression when no
Dox was added, indicating the repression by KRAB being leaky to a low extent.
Addition of 1 µg/ml Dox to ATF3/KRAB transduced mpkCCDCl14 cells grown
on coverslips during 3 days showed an induction of ATF3 expression which was
mostly located in the nucleus (see Fig. 24).
 
Figure 24: Overexpression of ATF3 in mpkCCDCl14 cells after 3 days of 1 mg/ml Dox:
Immunofluorescence staining using a polyclonal anti-ATF3 antibody (1:500). KRAB/ATF3
mpkCCDCl14 cells grown without Dox showed only very low levels of ATF3 expression as
compared to Dox-induced cells. WT mpkCCDCl14 cells served as a control where endogenous
ATF3 expression was below the detection limit of the antibody.
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Selection of mpkCCDCl14 clonal cell lines co-expressing ATF3 and KRAB
Limiting dilution led to isolation of clonal cell lines expressing both KRAB and
ATF3. These clones showed a Dox-inducible overexpression of the transcription
factor upon treatment with 1 µg/ml Dox for 3 days (see Fig. 25). Shown are
the examples for clones 1 and 11. In total 9 clonal mpkCCDCl14 ATF3/KRAB
expressing cell lines displayed Dox-inducibility of the transcription factor. An
endogenous level of ATF3 expression was seen in the WT mpkCCDCl14 cells,
however, it was not increased by Dox.
 
Figure 25: Dox-inducible ATF3 clonal mpkCCDCl14 cell lines: ATF3/KRAB mpkCCDCl14
Clones 1 and 11 were isolated by limiting dilution. They were grown ± 1 µg/ml Dox for 3
days to analyze induction of ATF3 overexpression (approximately 23 kD). WT mpkCCDCl14
cells were grown in parallel as a control. A clear induction of ATF3 expression was seen by
Western Blot after 3 days in ATF3KRAB mpkCCDCl14 clones treated with Dox when compared
to non-treated ATF3/KRAB mpkCCDCl14 transduced or WT mpkCCDCl14 cells.
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ATF3 overexpression is induced upon treatment with low Dox concentra-
tions in ATF3/KRAB transduced mpkCCDCl14 cells
To characterize the Dox-inducible overexpression of ATF3 in the mpkCCDCl14
cell lines, it was first tested whether the amount of overexpressed protein can
be regulated by varying the concentration of Dox in the medium. Fig. 26
shows the dose response to different Dox concentrations of clone 9 ATF3/KRAB
mpkCCDCl14 cells obtained by limiting dilution. Already the low dose of 0.1
µg/ml Dox showed a clear induction of ATF3 overexpression in ATF3/KRAB
mpkCCDCl14 cells compared to non-induced cells (0 µg/ml Dox) or non-transduced
WT mpkCCDCl14 cells. This effect increased with higher Dox doses up to 1
µg/ml.
 
Figure 26: Dose response of Dox-induced ATF3 expression. mpkCCDCl14 cells transduced
with ATF3 and KRAB were exposed to 0.1 µg/ml; 0.5 µg/ml; 0.75 µg/ml; 1 µg/ml and
1.5 µg/ml of Dox in the medium over a period of 3 days. Induction of ATF3 expression
(approximately 23 kD) compared to WT mpkCCDCl14 cells or no Dox treatment of ATF3/KRAB
mpkCCDCl14 clone 9 cells is observed even with the lowest dose of Dox (0.1 µg/ml). The
protein overexpression increases, the more Dox is added to the medium (up to 1 µg/ml).
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Dox-inducible overexpression of ATF3 in ATF3/KRAB transduced
mpkCCDCl14 cells is maintained over long periods of time
Next it was tested whether the cells do not lose the ability to induce ATF3
expression upon Dox-treatment over a longer culturing period including pas-
saging of the cells. The ATF3/KRAB transduced mpkCCDCl14 clone 1 cells
(ATF3/KRABCl1) were grown in two different concentrations of Dox (1.5 and 3
µg/ml) over a period of 15 days, with being passaged once. Furthermore the Dox
concentration at which ATF3 would be maximally induced was to be determined.
It was observed that ATF3/KRABCl1 mpkCCDCl14 cells were able to maintain
the expression of the transcription factor over the tested time period of 15 days.
At this timepoint, the induction was still as strong as it was after 3 days of Dox
treatment. Moreover, in the case of this particular clone, the strongest possible
induction seemed to be already reached with 1.5 µg/ml Dox, using twice this
dose of the antibiotic did not increase the overexpression of ATF3 any further
(see Fig. 27).
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Figure 27: Timecourse of Dox-induced ATF3 expression: WT mpkCCDCl14 cells trans-
duced with ATF3 and KRAB (clone 1, selected by limiting dilution) were exposed to 1.5 or
3 µg/ml of Dox in the medium over a period of 15 days, including passaging of the cells
once. Induction of ATF3 expression compared to WT mpkCCDCl14 cells or not Dox-treated
ATF3KRABCl1 mpkCCDCl14 cells was maintained over 15 days. The induction was similar,
regardless whether cells were grown in 1.5 µg/ml or 3 µg/ml Dox. Furthermore, the induction
did not lose its effectiveness even after 15 days.
Since we were able to demonstrate that clonal mpkCCDCl14 cell lines transduced
with ATF3 and KRAB showed Dox-inducible and dose dependent overexpression
of the transcription factor, which was maintained even after passaging, we
considered these cell lines to be suitable for functional studies of these cells.
Since ATF3 had been identified as aldosterone-induced gene product, we were
interested to test whether the ENaC-mediated Na+ current and its regulation by
aldosterone were altered in ATF3 overexpressing mpkCCDCl14 cells compared to
WT mpkCCDCl14 cells.
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5.1.3 Functional tests of ATF3/KRAB mpkCCDCl14 cell lines in Ussing
chamber
Before the mpkCCDCl14 ATF3 overexpressing cells were subjected to transep-
ithelial voltage clamp in an Ussing chamber set up, the transepithelial resistance
(TER) of the monolayer was confirmed to be sufficient (TER ≥ 1 kΩ), meaning
the cells formed a tight epithelium on the filter supports.
First the mpkCCDCl14 ATF3/KRAB mixed cell population and the clonal cell
line ATF3/KRABCl11 that were grown ± 1 µg/ml Dox for 3 days were compared
in terms of their transepithelial transport characteristics. The cells were voltage
clamped (see methods section 4.5) and transepithelial short circuit current was
measured. The cells were allowed to stabilize in the new environment of the
chamber (minimal medium warmed to 37°C and pH equilibrated with constant
gas supply of 95% O2 and 5% CO2) until the short circuit currents measured
reached a stable plateau, in the case of this first experiment after approximately 2
h. 1 µM aldosterone was then added to the medium in the chamber surrounding
the cells (residing on filters) to stimulate Na+ transport by the epithelial Na+
channel ENaC via the glucocorticoid receptor (GR), since mpkCCDCl14 cells do
not have endogenous expression of the aldosterone receptor mineralocorticoid
receptor (MR). After about 3 h, arginine-vasopressin (AVP) was added to the
medium to stimulate ENaC mediated Na+ transport via another signalling route,
namely the cyclic AMP (cAMP) signalling pathway for approximately 2 h. At the
end of the transepithelial current measurements, the diuretic amiloride was added
to specifically block ENaC and abrogate Na+ transport (see Fig. 28 A+B).
All cells showed a steep increase in transepithelial currents during the first two
hours of the experiment. The levels of the currents observed once they stabilized
were very different from one filter to the other ranging from approximately 13 up
to 61 µA, once a stable condition was reached. After addition of aldosterone to
the medium in the chamber, only cells treated with Dox showed an increase in
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currents of approximately 10 µA for the mixed population and approximately 20
µA for the clonal cell line. However, both these filters showed lower currents after
the stabilization period than were observed in their non-induced counterparts.
Addition of AVP lead to an increase in currents measured in all samples, which
was most pronounced in the clonal cell line overexpressing ATF3. Addition of
amiloride blocked the currents to a comparable level of around 3.5 µA in all the
samples (Fig. 28 A), suggesting that the currents measured were Na+ currents
mediated by ENaC. Also transepithelial resistances increased during the phase of
stabilization until they reached approximately 3 kΩ which is considerably high.
The transepithelial resistances decreased in the mixed population of ATF3/KRAB
mpkCCDCl14 cells or the ATF3/KRABCl11 mpkCCDCl14 cell line treated with
Dox as was expected to go along with the increases in transepithelial currents.
Amiloride blocked ENaC and ablated Na+ currents, which led to an increase of
transepithelial resistance in all chambers up to 6 kΩ (see Fig. 28 B).
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Figure 28: A: Original trace of Ussing chamber short circuit currents of ATF3/KRAB
mpkCCDCl14 mixed population and ATF3/KRABCl11 mpkCCDCl14 under voltage clamp:
Addition of 1 µM aldosterone only stimulated transepithelial currents in cells treated 3 days
with 1 µg/ml Dox in both clonal and mixed populations of ATF3 overexpressing cells, while
addition of 10 nM AVP increased currents in all cell populations. Addition of 10 µM amiloride
blocked the currents in all samples to 3.5 µA, suggesting that the observed transepithelial
currents are ENaC-mediated Na+ currents.
B: Transepithelial resistances of ATF3/KRAB mpkCCDCl14 mixed population and
ATF3/KRABCl11 mpkCCDCl14 under voltage clamp: Transepithelial resistances of all
cells measured confirmed that the cells grew in tight monolayers. Up to 3 kΩ of transepithelial
resistance was reached as in the case of ATF/KRAB mpkCCDCl14 mixed population grown
with 1 µg/ml Doxycycline for 3 days. The resistances decreased upon addition of 1 µM
aldosterone or 10 nM AVP because these agents increased the transepithelial short circuit
currents by opening a Na+ conductance. Addition of 10 µM amiloride to the medium chambers
immediately led to a rise of resistance in all samples measured up to 6 kΩ, confirming that
the observed current and decrease in resistance was due to ENaC-mediated Na+ transport.
In the next step the goal was to verify the data obtained from Fig. 28 using
additional clones. Furthermore, it was to be confirmed that the transduction of
ATF3 and KRAB per se, without inducing the Overexpression of ATF3 would
not alter transepithelial currents compared to WT cells. Thus, we subjected
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ATF3/KRABCl1 and Cl13 mpkCCDCl14 cells to transepithelial current mea-
surements in Ussing chamber. ATF3/KRABCl13 mpkCCDCl14 cells showed
approximately the same short circuit currents independent of whether they were
induced to overexpress ATF3 or not (see Fig. 29 B respectively A). In clone 1
there was a clear difference in the cells grown for 3 days with Dox compared
to non-induced cells. The baseline currents in the ATF3 overexpressing cells
were around 30 µA higher (approximately 85 µA) than in the same clone grown
without Dox (approximately 55 µA. However, the transepithelial resistance stayed
about the same for both induced and non-induced ATF3/KRABCl1 cells, namely
about 1 kΩ. Surprisingly stimulation by addition of 1 µM aldosterone to the
chambers did not alter transepithelial currents in any of the tested cells (WT,
ATF3/KRABCl1 or Cl13), independent of Dox-induction. ATF3/KRABCl1
mpkCCDCl14 cells always showed higher short circuit currents, than the WT
mpkCCDCl14 cells (approximately 7-fold higher), no matter if they were induced
to overexpress ATF3 or not. Unexpectedly, the currents of the WT mpkCCDCl14
were higher when grown with Dox than when grown without the Dox. In the
whole experiment, neither aldosterone nor addition of 10 nM AVP had an ef-
fect on the currents measured in any cell type. Addition of 10 µM amiloride
completely blocked the currents measured in all the cell populations, which was
accompanied by a rise in resistance. Therefore the currents observed must have
been ENaC-mediated Na+ currents.
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Figure 29: A+B: Original trace of Ussing chamber short circuit currents of
mpkCCDCl14 WT, ATF3/KRABCl1 mpkCCDCl14 and ATF3/KRABCl13 mpkCCDCl14
grown without Doxycycline (A) or with 1 µg/ml Doxycycline for 3 days (B): WT
mpkCCDCl14 cells aswell as ATF3/KRABCl13 cells all showed about 10-20 µA throughout the
whole experiment. Regardless of the baseline level of current of unstimulated cells, none of
the cell populations showed any reaction in terms of transepithelial currents in response to
stimulation with 1 µM aldosterone or 10 nM AVP, independent of ATF3 overexpression.
C+D: Transepithelial resistances of mpkCCDCl14 WT, ATF3/KRABCl11 mpkCCDCl14
and ATF3/KRABCl13 mpkCCDCl14 grown without Doxycycline (C) or with 1 µg/ml
Doxycycline for 3 days (D): As can be observed in the transepithelial resistances, the cells
formed tight monolayers. This was not altered upon hormone addition to the medium. 10 µM
amiloride increased the transepithelial resistance in all the cell samples by blocking ENaC.
The experiment shown above was the first one not to give reproducible results
from Ussing chamber measurements anymore. Additionally it was disturbing that
Dox per se increased transepithelial currents in WT mpkCCDCl14 cells. We were
also no longer able to reproduce the experiments that were formerly performed
in the laboratory (by Dr. Gabriele Adam), even though we were controlling
pH and temperature of the medium during the experiment. Surprisingly, even
the mpkCCDCl14 WT cells did not seem to respond to aldosterone anymore by
increased transepithelial currents. This problem was also observed in another
mouse cortical collecting duct cell line, the mCCDCl1 cells, in two other laborato-
ries (Prof. Olivier Staub in Lausanne, Switzerland and Prof. Johannes Loffing
in Zurich, Switzerland). Trying to optimize growth and differentiation media,
number of cells seeded on the filters, coating conditions of filters and testing of
different lots of FCS did not improve the situation (data not shown).
The initial rational why mpkCCDCl14 cells were chosen over mCCDCl1 cells to
be used as a cell culture model was that mpkCCDCl14 cells seemed much more
stable in terms of transepithelial transport characteristics over the different
passages during the culturing period. However, the disadvantage of working with
mpkCCDCl14 cells is, that they do not express the mineralocorticoid receptor
(MR) endogenously, which is the specific aldosterone receptor. This is the reason
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why compared to the physiological level, which is in the nanomolar range, an
unreasonably high dose of aldosterone has to be added to the medium (1 µM) to
stimulate Na+ transport in these cells more unspecifically over the glucocorticoid
receptor (GR) signalling pathway (see Ussing chamber results Fig. 28) [108] [109].
The laboratories of Prof. Bernard Rossier and Prof. Olivier Staub isolated a new
mCCD clonal cell line, the clone 6, which happened to be much more stable over
the passages and gave considerable aldosterone responsiveness at lower levels of
aldosterone in Ussing chamber experiments of these research groups. The cells
were tested in our Ussing chamber and increased transepithelial short circuit
currents with 300 nM aldosterone treatment after 1 h were observed. 10 nm
AVP was able to further increase these currents. Final treatment of mCCDCl6
cells with 10 µM amiloride ablated the currents observed before to a minimum,
therefore pointing to the fact that the currents observed are ENaC-mediated Na+
currents (see Fig. 30).
Therefore from this time point on, we decided to continue our work with mCCDCl6
cells and to not further use the mpkCCDCl14 cells, neither the WT nor the
ATF3KRAB transduced ones.
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Figure 30: Original trace of Ussing chamber short circuit currents (A) and resistances
(B) of mCCDCl6 WT cells: WT mCCDCl6 were tested for their capability to respond to
aldosterone stimulation. After the initial stabilization period of approximately 1 h, 2 filters were
treated with 300 nM aldosterone while 2 filters were left untreated. All filters had stabilized
their short circuit currents around approximately 9-18 µA. After approximately 1 h, cells treated
with aldosterone increased short circuit currents up to approximately 60 µA, while short circuit
currents of non-treated cells remained stable. Addition of 10 nM AVP to all cells increased the
short circuit currents in all samples, with a more pronounced increase in cells that had so far
been unstimulated (approximately 30 µA). Treatment with 10 µM amiloride abrogated most of
the transepithelial current seen, confirming that the increased short circuit currents in response
to aldosterone or AVP treatment are Na+ currents due to enhanced ENaC activity. The jump
in currents and resistance after approximately 170 min is due to unstable electrodes.
5.1.4 ATF3 relative mRNA expression is upregulated upon medium
change in mCCDCl6 cells in vitro
When we first aimed at characterizing the new mCCDCl6 cells, we were interested
whether we could see an early aldosterone induced upregulation of ATF3 on the
mRNA level, as we did in mpkCCDCl14 cells (see Fig. 22).
When treating mCCDCl6 cells with aldosterone in a time-course experiment, a
student co-worker replaced the old medium that had been on the cells for 2
days with fresh medium containing aldosterone, instead of diluting the hormone
directly into the medium that already had been on the cells. As a negative control
cells were not treated with aldosterone, but also in this condition the medium
was also replaced with fresh medium. This treatment of the negative control
and the 24h-aldosterone treatment were performed at the same time. This had
the effect of inducing ATF3 mRNA levels relative to this control. There was a
most prominent ATF3 mRNA expression peak after 1 h during a 24 h-timecourse,
showing an approximately 6-fold induction compared to control. SGK1 served as
a positive control, since it is an aldosterone-induced gene. Relative SGK1 mRNA
levels only showed a tendency to increase after 24 h (see Fig. 31). It was decided
that the upregulation of ATF3 observed from this experimental set-up cannot
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completely be attributed to be aldosterone-mediated, since the medium change
per se might possibly have an effect on the expression of specific genes. It could
have been the medium change per se and not the aldosterone added with the
medium that was responsible for the upregulation of ATF3 mRNA levels after 1h.
We suspected that it is possibly a kind of stress caused by the medium change
that induces the expression of the transcription factor after 1 h rather than the
hormone. 
Figure 31: Aldosterone increases relative ATF3 mRNA expression when added with
a medium change in mCCDCl6 cells. Relative mRNA expression of ATF3 and SGK1 in
mCCDCl6 cells in response to 1 µM aldosterone treatment for 1 h, 3 h, 6 h and 24 h was
analyzed. In this experimental set-up, 1 µM aldosterone was added to the cells by replacing
the old medium on the cells with fresh medium in which the aldosterone was diluted. This led
to an approximately 6-fold induction of relative ATF3 mRNA expression while SGK1 mRNA
levels showed a tendency of increasing after 24 h. Values are expressed relative to a control (no
aldosterone = 1, represented by the black line) in which the medium had been replaced with
fresh medium (without aldosterone) at the same timepoint as the 24h-aldosterone treatment
started. N=3, house keeping gene: HPRT, error bars= SEM. Unpublished Data (Cand. med.
Christoph Rüst)
To further confirm the hypothesis, that the medium change and not the aldos-
terone had an effect on ATF3 expression, the co-worker performed an experiment
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where he added the aldosterone directly to the medium that had already been
on the mCCDCl6 cells for 24 h and lysed these cells after 1 h, 3 h, 6 h and 24
h to analyze mRNA expression patterns. A clear induction of SGK1 mRNA
expression with a peak after 3 h could be observed, while relative mRNA levels
of ATF3 seemed unaltered even though aldosterone was present in the medium
(see Fig. 32). 
Figure 32: Aldosterone does not induce ATF3 expression in mCCDCl6 cells when added
without a medium change: When 1 µM aldosterone was added to the WT mCCDCl6 cells
without changing the medium, and incubated for 1 h, 3 h, 6 h or 24 h, there was only a
relative upregulation of SGK1 mRNA, which was strongest after 3 h when expressed relative to
non-treated cells. However, the ATF3 mRNA levels of cells treated with aldosterone that was
added directly to the medium stayed unaltered over time. Values are expressed relative to a
control (no aldosterone = 1, represented by the black line). N=3, house keeping gene: HPRT,
error bars= SEM. Unpublished Data (Cand. med. Christoph Rüst).
An additional experiment in which mCCDCl6 cells underwent only a medium
change with minimal medium (no aldosterone added), ATF3 mRNA levels were
clearly increased after 1 h, namely 25-fold higher than after 24 h. SGK1 expression
levels were slightly lower due to the medium change (see Fig. 33)
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Figure 33: Changing the medium mCCDCl6 of cells induces relative expression of ATF3
mRNA: The minimal medium of mCCDCl6 cells was changed 1 h or 24 h prior to lysis. There
is a strong increase in relative expression levels of ATF3 mRNA observed when cells were lysed
after 1 h compared to cells lysed after 24 h. This effect was not as pronounced for relative
SGK1 expression levels. N=3, all values relative to HPRT mRNA expression, error bars= SEM.
Unpublished Data (Cand. med. Christoph Rüst).
The results from these cell culture experiments were unexpected and showed
that a simple medium change is enough to stimulate ATF3 mRNA expression
in mCCDCl6 cells and that it is not aldosterone that is responsible for this
upregulation in this cell linein vitro. Moreover, this is not the case for SGK1,
here a medium change only has a small effect, while it is up to 7-fold induced by
the hormone.
Retrospectively, also the upregulation of ATF3 in mpkCCDCl14 WT cells upon
aldosterone stimulation (see Fig. 22) could have been due to the medium change,
since also this co-worker replaced the medium with fresh aldosterone-containing
medium instead of diluting the hormone directly in the conditioned medium
that had been on the cells before. It needed to be tested which aspect of the
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medium change was responsible for the induction of ATF3 mRNA by the medium
change. On one hand it could be due to the fact that when the old medium is
replaced by fresh one, certain substances that were released into the supernatant
were removed while fresh factors were supplied. On the other hand it might be
simply the mechanical stimulation of the cells that lets them produce more of
the transcription factor mRNA.
Hence, an experiment comparing mCCDCl6 cells not treated at all to cells that
underwent two different kinds of medium change was carried out: First, a mock
medium change, which meant to aspirate the conditioned minimal medium
(without growth factors or FCS) from the cells that had been there for 24 h and
immediately redistributing it back onto the cells and second, a real medium change
where the old medium was discarded and fresh in a tube pre-warmed (37°C)
minimal medium was put on the cells. Performing qPCR of cells treated with these
different medium changes for 1 h revealed that a mock change showed a tendency
to upregulate relative ATF3mRNA compared to non-treated controls. A real
change of medium, replacing the old medium on the cells led to a approximately
5-fold upregulation of relative ATF3 mRNA expression (normalized to HPRT
mRNA expression levels) compared to untreated cells (see Fig. 34). None of
the medium changes had an effect on SGK1 expression. With this experiment
the conclusion from the previous experiment could be confirmed, namely that
ATF3 is an early stress-induced response gene, rather than an early-aldosterone
induced gene.
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Figure 34: Relative ATF3 mRNA expression is induced after 1 h due to medium
change in mCCDCl6 cells: mCCDCl6 cells were serum and growth factor starved for 24 h.
Then cells either underwent no medium change, a mock change where the medium on the
cells was withdrawn and put back on the cells immediately or a change of medium replacing
the old medium with fresh minimal medium pre-warmed in a tube (37°C). After 1 h, only
exchanging the old medium with fresh medium pre-warmed in a tube led to an approximately
5-fold increase of ATF3 mRNA expression (normalized to HPRT mRNA expression).This was
not observed for SGK1 expression. N=4; ** = p < 0.01 t-test and 1-way ANOVA, error bars:
SEM. The result relative to Actin is represented in supplementary figure 2.
When analyzing the expression of ATF3 on the protein level it was found to be
endogenously expressed at very low levels in untreated mCCDCl6 cells. After
treating the cells with either no medium change, a mock or a real medium change,
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there was a slight increase in ATF3 protein levels seen 1 h after the treatment
(see Fig. 35).
 
Figure 35: ATF3 expression is induced on the protein level after 1 h medium change
in mCCDCl6 cells: mCCDCl6 cells were serum and growth factor starved for 24 h. Then cells
either underwent no medium change, a mock change where the medium on the cells was
withdrawn and put back on the cells immediately or a change of medium replacing the old
medium with fresh minimal medium pre-warmed in a tube (37°C). Using a polyclonal antibody
against mouse ATF3 (approximately 23 kD), a slight induction of ATF3 protein after 1 h after
exchanging the old medium with fresh medium with pre-warmed in a tube is seen in Western
blot (40 µg cell lysate loaded per lane).
5.1.5 JNK/SAPK1, ERK1/2 and p38 phosphorylation are increased
mCCDCl6 cells upon the stress of medium change
This chapter describes the work that has been done to investigate which signal
transduction pathways might be responsible for the observed increase in ATF3
mRNA and protein levels in mCCDCl6 after a medium change of 1 h (see Fig. 34
and 35).
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The literature reports ATF3 to be induced by several pathways of MAPK sig-
nalling (see introduction 3.2.2.). We therefore tested whether the medium change
induces an increase in phosphorylation of the MAPK p38, JNK or ERK, which
could be responsible for the subsequent increase in ATF3 protein by phosphory-
lating transcription factors that control ATF3 gene expression. However, MAPK
phosphorylation is a process of minutes, which might then lead in the end to a
delayed ATF3 upregulation after 1 h. Therefore the cells were lysed shortly after
the medium change, seven min instead of 1 h to be sure not to miss the phospho-
rylation events of the MAPK. Also the different properties of the medium change
were redefined. The control cell lysates (no medium change) were compared to
(1) mock medium changed lysates (aspirating and immediately putting back the
same medium on the cells), (2) a medium change where fresh medium was used
that was pre-warmed in a tube to 37°C, (3) a medium change where the fresh
medium was allowed to CO2-equilibrate and pre-warm in the incubator at 37°C,
or (4) a conditioned medium change where the medium from one well of cells
was transferred to another. This allowed investigating whether the cells might
produce an inhibitor that would prevent MAPK phosphorylation.
A clear induction of phosphorylation of JNK/SAPK1 could be observed only
in mCCDCl6 cells treated with a medium change with medium pre-warmed in
a tube (see Fig. 36). For all other conditions phosphorylation levels of the
MAPK remained low. Analyzing total JNK/SAPK1 content in the cells revealed
that the tube pre-warmed medium change condition showed a band migrating
slightly higher than in the other conditions. Admitting that this slightly higher
band corresponds to the phosphorylated form of JNK, this would indicate that
a substantial proportion of JNK was phosphorylated in this condition. This is
coherent with the increased phosphorylation seen in this treatment when using
the phospho-specific JNK/SAPK1-antibody.
Western blots using phospho-specific antibodies against the MAPK ERK1/2 also
showed the similar patterns observed for JNK/SAPK1 phosphorylation: Only
when the medium was replaced with fresh medium that had been pre-warmed
90
5 Results
in a tube at 37°C, a higher phosphorylation of ERK1/2 was seen in mCCDCl6
cells compared to all other conditions (see Fig. 37), while total levels of ERK1/2
protein stayed approximately the same in all samples.
Finally, also p38, the third MAPK investigated showed similar behavior when
treated with the different medium changes. Also in this case it is the change with
medium pre-warmed in a closed tube that led to the strongest induction of p38
phosphorylation while the total protein content stayed mostly constant (see Fig.
38).
 
Figure 36: JNK phosphorylation is increased in mCCDCl6 cells upon the stress of
medium change: mCCDCl6 cells were growth factor and serum starved overnight. Then they
were subjected to different medium changes: (1) A mock change, meaning the medium is
aspirated and the same medium is added back to the cells immediately, (2) a medium change
where the old medium is replaced by fresh minimal medium that was pre-warmed in a tube, (3)
a medium change where the old medium is replaced by fresh medium that was CO2-equilibrated
and pre-warmed in the incubator, (4) a conditioned medium change where the medium is
taken from one well of cells and put onto another. All cells were lysed seven min after the
medium change took place. As a control, cells were lysed immediately, without a medium
change. A clear induction of JNK/SAPK1 (approximately 43 and 56 kD; positive control HeLa
+ Ascinomycin lysate) phosphorylation is seen only when the medium on the cells was replaced
with medium pre-warmed in a tube. Total JNK/SAPK1 (approximately 49 kD; positive control
PC12 lysate) amounts stay approximately the same in all conditions.
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Figure 37: pERK1/2 phosphorylation is increased in mCCDCl6 cells upon the stress
of medium change:mCCDCl6 cells were subjected to different medium changes: (1) A mock
change, meaning the medium is aspirated and the same medium is added back to the cells
immediately, (2) a medium change where the old medium is replaced by fresh minimal medium
that was pre-warmed in a tube, (3) a medium change where the old medium is replaced by
fresh medium that was CO2-equilibrated and pre-warmed in the incubator, (4) a conditioned
medium change where the medium is taken from one well of cells and put onto another. All
cells were lysed seven min after the medium change took place. As a control, cells were lysed
immediately, without a medium change. A: All conditions showed about equal amounts of
total ERK1/2 protein (approximately 42/44 kD). B: An induction of ERK1/2 phosphorylation
(approximately 42/44 kD) is seen only when the medium on the cells was replaced with medium
pre-warmed in a tube and in none of the other conditions.
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Figure 38: p38 phosphorylation is increased in mCCDCl6 cells upon the stress of
medium change:mCCDCl6 cells were subjected to different medium changes: (1) A mock
change, meaning the medium is aspirated and the same medium is added back to the cells
immediately, (2) a medium change where the old medium is replaced by fresh minimal medium
that was pre-warmed in a tube, (3) a medium change where the old medium is replaced by
fresh medium that was CO2-equilibrated and pre-warmed in the incubator, (4) a conditioned
medium change where the medium is taken from one well of cells and put onto another. All
cells were lysed seven min after the medium change took place. As a control, cells were lysed
immediately, without a medium change. A: All conditions showed about equal amounts of
total p38 protein (approximately 42 kD). B: The highest induction of p38 phosphorylation
(approximately 42k D) was observed when the medium on the cells was replaced with medium
pre-warmed in a tube.
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5.2 Regulation and impact of ATF3 expression in mouse kidney
(tubules)
5.2.1 NaCl-injection upregulates ATF3 expression but not SGK1
expression specifically in the kidney in vivo
The in vitro findings in mCCDCl6 cells shown in the previous section made us
hypothesize that the induction of ATF3 could be due to stress as well in vivo.
Since the control mice in the experiment that initially led to the conclusion that
ATF3 is an early-aldosterone induced gene were not injected with a physiological
saline solution, there was the possibility that the relative upregulation of ATF3
mRNA was due to the stress of the handling and injection, rather than the injected
hormone itself. Thus, we hypothesized that a simple injection of a physiological
saline solution might be enough to upregulate ATF3 mRNA expression in mice
due to a stress reaction (see 3. general introduction). To test whether this
reaction would be limited specifically to certain organs of the body, one group of
WT C57BL/6 mice was injected with 0.9% NaCl / 0.3% ethanol (the vehicle used
for the initial aldosterone-injection experiments) and sacrificed after 1 h while
another group of mice was euthanized immediately. Total RNA was extracted
from kidney, brain, colon mucosa and heart. qPCR analysis showed that 1 h after
the mice were injected with 0.9% NaCl / 0.3% ethanol, the mRNA expression
of ATF3 was upregulated specifically in the kidney, compared to non-injected
mice (see Fig. 39). This effect was not observed in the other organs tested.
In addition, the expression of SGK1 was not altered upon injection of saline
solution after 1 h. This was expected since SGK1 has been shown repeatedly to
be induced specifically by aldosterone and always served as a positive control
in experiments where mice were treated with the hormone. In addition, this
result is analogous to the observation made in the in vitro studies in mCCDCl6
cells. Thus, we conclude that the 4-fold upregulation of relative ATF3 mRNA
expression (normalized to HPRT) in vivo is a specific immediate stress response
and this effect is specific for the kidney.
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Figure 39: Expression of ATF3 and SGK1 in different mouse organs upon NaCl-
Injection in WT C57BL/6 mice: 3 mice per group were either not treated or injected with
0.9% NaCl / 0.3% ethanol. All mice were sacrificed after 1 h. Subsequent total RNA extraction
and qPCR shows upregulation of relative ATF3 mRNA expression in the kidney about 4-fold
due to injection of saline as compared to mice that have not been injected until they were
sacrificed. In brain this effect is only slightly seen as a tendency while in heart and mucosa
scraped from the colon there was no difference in ATF3 expression observed. SGK1 mRNA
expression is unaffected by injection of the saline solution in all the organs tested (kidney, heart,
brain and colon mucosa, normalized to HPRT mRNA expression levels) *** = p < 0.001 with
student t-test (unpaired) and 1-way-ANOVA. Error bars: SEM. The result represented relative
to actin is shown in supplementary fig.1.
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The effect of the injection of 0.9% NaCl / 0.3% ethanol was not only restricted
to the mRNA level in mouse kidneys. Analyzing whole kidney protein lysates
using a mouse polyclonal antibody against ATF3 in Western blots shows that
ATF3 is also upregulated on the protein level upon injection when compared to
WT mice (see Fig. 40).
 
Figure 40: Injection of 0.9%NaCl / 0.3% EtOH induces ATF3 protein expression after
1 h in mouse kidney: 3 WT C57BL/6 mice per group were either not treated or injected
with 0.9% NaCl / 0.3% ethanol. All mice were sacrificed after 1 h. In total kidney lysates
of NaCl/EtOH injected WT mice ATF3 protein expression (approximately 23 kD, polyclonal
antibody 1:500, 40µg of protein loaded per lane) was upregulated compared to the non-injected
control group. *** = p< 0.001, student t-test (unpaired). Error bars: SEM.
5.2.2 Injection of NaCl/EtOH has no effect on ATF3 mRNA expression
but increases protein expression in CNT/CCD
Sorting of kidney tubule segment by COPAS
The original experiment underlying this thesis was performed on micro-selected
kidney tubules of the ASDN (CNT/CCD), to allow studying the effect of aldos-
terone injection on gene expression in this specific part of the kidney. Therefore
the question was asked whether the upregulation of ATF3 mRNA as a response
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to the stress of an injection was also present and possibly even more pronounced
in the ASDN. Micro-selecting tubules is a time-consuming task and the yield of
material is usually low. Therefore it was sought to use an automated technique
to select more tubules of the ASDN in less time, so that there would be enough
material to not only study changes in mRNA expression but also at the protein
level. The complex object parametric analyzer and sorter (COPAS) is a machine
originally constructed to sort fluorescent C.elegans worms but can also be used
to sort kidney tubules. The B1GEFP mouse expresses EGFP under the control
of the promoter for the B1 subunit of the V-ATPase. This promoter is especially
activated in intercalated cells of the CNT/CCD which leads to a specific expres-
sion of the fluorescent protein in this kidney tubule segment. 3 groups of mice
(11-14 weeks old) were used to select CNT/CCD from: 4 WT B1EGFP C57BL/6
mice that were not injected (control mice), 4 WT B1EGFP C57BL/6 mice that
were injected with 0.9% NaCl / 0.3% EtOH and sacrificed after one hour, and
4 non-injected B1EGFP ATF3 KO C57BL/6 mice that do not express ATF3
protein. For all mice a GFP fraction was sorted, assuming to be constituted of
CNT/CCD tubules. To get a means of the quality of the sort, also a GFP-negative
fraction (whole kidney cortex without green fluorescent CNT/CCD) and the
whole kidney cortex were sorted. Total mRNA was extracted from approximately
4000-5600 sorted tubules and analyzed with qPCR. To check for specificity of the
GFP-sorted tubules, we looked at the water channel aquaporine 2 (AQP2) and
ENaC which should be enriched in the CNT/CCD fraction as compared to the
negative tubules and the whole kidney cortex fraction. Indeed this was the case
(see Fig. 41). Furthermore the proximal tubule sodium/phosphate co-transporter
NaPi2a was lower in the GFP-sorted fractions as opposed to the GFP-negative
fraction or whole kidney cortex. The Na/Cl-co-transporter NCC is expressed in
the DCT. It was also enriched in the GFP-negative fraction and the whole kidney
cortex compared to GFP-sorted tubules on both injected and non-injected mice.
We conclude that the GFP-positive sorted material in all three mouse groups
shows the expected gene expression profile of CNT/CCD.
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Figure 41: Characterization of COPAS-sorted tubule segment. Expression of specific
genes was compared in the different tubule fractions: GFP positive (CNT/CCD) vs. GFP-
negative tubules and total cortex tubules (pooled from 12 mice). Four mice per group
(non-injected vs. 0.9% NaCl / 0.3% EtOH injected for 1 h) and ATF3 KO B1EGFP C57BL/6
mice) were sacrificed and kidney tubule suspensions were sorted with COPAS. Total RNA
extraction and qPCR was performed. The CNT/CCD markers AQP2 and ENaC were enriched
in the GFP-positive fractions compared to the negative fraction or whole kidney. This is
accompanied by a lower expression of NaPi2a (proximal tubule) and NCC (DCT) in the
GFP-sorted fraction compared to the other two fractions. All values of gene expression are
relative to HPRT mRNA expression. * compares WT non-injected to WT injected mice; $
compares WT non-injected to ATF3 KO non-injected mice; # compares WT injected to ATF3
KO mice. *, $ and # = p < 0.05; **, $$ and ## = p < 0.01; *** = p < 0.001 with student
t-test (unpaired). Error bars: SEM.
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Three genes of interest were investigated whether they were regulated specif-
ically in the COPAS sorted CNT/CCD fraction: ATF3, ATF4 and CHOP10.
First, ATF3 mRNA expression was measured to test whether the injection of
NaCl/EtOH has an even stronger effect on the relative mRNA expression of this
transcription factor in this specific kidney segment than had been observed in
whole kidney lysates beforehand. Second, the effect of the injection on ATF4
was examined, an upstream factor of ATF3 which is know to bind to the ATF3
promoter and to induce its transcription [110]. Last, the influence of the saline
injection on expression of CHOP10, a target repressed by ATF3, was studied
[49].
Effect of saline injection on mRNA expression in WT C57BL/6 WT mice
and comparison with ATF3 KO mouse
Surprisingly the expected induction of relative ATF3 mRNA expression could not
be observed in the CNT/CCD fraction when WT B1EGFP mice were injected
with 0.9% NaCl / 0.3% EtOH for 1 h when compared to non-injected WT
B1EGFP control mice (see Fig. 42). In the GFP-negative fraction and the whole
kidney cortex the expected upregulation of ATF3 mRNA levels was seen as a
tendency in injected WT B1EGFP mice compared to non-injected mice. As
expected there was no expression of ATF3 in the ATF3 KO B1EGFP mice.
CHOP10 expression was not changed in WT B1EGFP mice in the CNT/CCD
fraction; it was the same in all three groups of mice tested. Only in the GFP-
negative sorted fraction CHOP10 mRNA levels showed a tendency to be decreased
with the injection and even were lower in the ATF3 KO B1EGFP mouse.
ATF4 mRNA was equally expressed throughout all three fractions sorted by the
COPAS. Also there was neither a difference observable between WT and ATF3
KO mice nor between the non-injected and injected mice.
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Figure 42: Effect of i.p. vehicle injection on gene expression in the different tubule
fractions compared to non-injected and ATF3 KO mice.The GFP-sorted fraction (CN-
T/CCD), GFP-negative-sorted fraction and whole kidney cortex were sorted from WT B1EGFP
(non-injected vs. 0.9% NaCl / 0.3% EtOH injected for 1 h) and ATF3 KO B1EGFP C57BL/6.
Four mice per group were sacrificed and kidney tubule suspensions were sorted with COPAS.
Total mRNA extraction and following qPCR was performed. Gene expression was normalized
relative to HPRT expression in the different mouse groups and then normalized to the non-
injected WT B1EGFP mice (= 1). Relative levels of ATF3 mRNA were not altered by the
stress of NaCl/EtOH injection in the CNT/CCD (GFP-positive) sorted fraction in WT B1EGFP
mice compared to non-injected WT B1EGFP mice. The injection only showed a tendency to
increase in ATF3 mRNA levels in the GFP-negative sorted and the whole kidney cortex fraction
of the injected WT B1EGFP mice compared to control. As expected, ATF3 expression was
missing in the ATF3 KO B1EGFP mice. No effect of the injection or the lack of ATF3 in the
KO mice was observed in relative mRNA expression levels of ATF4 throughout all the fractions.
The expression of the ATF3 target protein CHOP10 mRNA is decreased in the negative sorted
fraction of injected WT B1EGFP mice compared to the non-injected control and even lower
in the ATF3 KO mice. In ATF3 KO mice, a trend of higher SGK1 levels compared to WT
non-injected mice was observed in the GFP-negative and the whole kidney cortex fraction.
N=4; except negative kidney fractions of WT non-injected and WT injected mice (N=2). *
compares WT non-injected to WT injected mice; $ compares WT non-injected to ATF3 KO
non-injected mice. $ = p< 0.05; ** and $$ = p< 0.01 with student t-test (unpaired). Error
bars SEM.
The expected upregulation of ATF3 by the saline injection could not be observed
on the mRNA level in CNT/CCD sorted tubules. However, when analyzing
protein lysates of these tubules, a clear induction of ATF3 protein due to the
injection was observed in B1EGFP WT mice compared to the endogenous ATF3
level in non-injected B1EGFP WT mice. Also CNT/CCD lysates from ATF3 KO
mice do not show this band at the level of 23 kD where ATF3 protein is expected
to migrate, confirming the antibody specificity (see. Fig 43 A). Furthermore,
expression of AQP2 was unaffected by the injection of 0.9% NaCl / 0.3% EtOH
in CNT/CCD of B1EGFP WT mice and B1EGFP ATF3 KO mice (see Fig 43
B).
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Figure 43: ATF3 protein expression is upregulated due to injection of NaCl/EtOH in
CNT/CCD of B1EGFP WT mice: The GFP-sorted fraction (CNT/CCD) of WT B1EGFP
mice (non-injected (NI WT) vs. 0.9% NaCl / 0.3% EtOH injected (Inj WT) for 1 h) and ATF3
KO B1EGFP mice were investigated for ATF3 protein expression. A: Western blot analysis
shows a clear induction of a band migrating at the expected size for ATF3 protein (ca. 23 kD)
in injected B1EGFP WT mice compared to non-injected littermates. Basal ATF3 expression in
non-injected mice is almost not detectable in WT B1EGFP CNT/CCD tubule lysates. The
band is absent in non-injected ATF3 KO mice. B: Western blot analysis using an antibody
against AQP2 reveals a band running at 35 kD corresponding to the glycosylated form of the
water channel, while the weaker band running at 25 kD represents unglycosylated AQP2. The
injection of 0.9% NaCl / 0.3% EtOH did not significantly influence the expression of AQP2 in
B1EGFP WT mice compared to non-injected B1EGFP WT mice and B1EGFP ATF3 KO mice.
Approximately 400 tubules were loaded per lane, N=4. Error bars: SEM.
102
5 Results
5.2.3 Characterization of ATF3 knockout mouse
Since there have only been a few studies using isolated cells from the ATF3
KO mouse[105] and no description of its phenotype has been published, it was
decided to perform metabolic cage experiments to characterize parameters in
comparison to WT C57BL/6 mice. Mice were placed into metabolic cages for
an accommodation phase of two days with one day of resting phase in between.
Then they were kept in the metabolic cage for the experimental period of four
consecutive days (see Fig. 44) to determine water and food consumption, as well
as urine and feces production and to follow the weight gain or loss. On the third
day of the experiment, we challenged the mice with a 23-hour-water-deprivation.
If ATF3 played an important role specifically in the kidney (that might be
stress-related) the knockout mice might show different ability of coping with this
insult.
 
Figure 44: Timecourse of metabolic cage experiments to characterize WT C57BL/6
vs. ATF3 KO mice: First the mice were allowed to adapt to the metabolic cages two times
for one day with a one- or a two-day break in normal cages in between. Then the animals were
kept in metabolic cages for two days without any stress challenge. On the third day no water
was supplied to the animals for 23 hours (water deprivation). On the 4th day of the experiment,
mice were allowed to drink again (rehydration). After another day, the animals were sacrificed.
During the whole experiment animals were weighed and food/water consumption as well as
urine/feces production was determined.
Over the whole period of the experiment the ATF3 KO animals had a tendency
to weigh slightly less (approximately 1 g) than the WT mice. The weight changes
were paralleled over the timecourse of the experiment in both groups. Both
ATF3 KO as well as WT mice showed a similar transient drop in weight upon
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23-h-water-deprivation (see Fig. 45 A).
The food and water consumption was the same for WT or ATF3 KO animals
over the whole period in the metabolic cage, including the water deprivation
(see Fig. 45 B and C). On this day, along with the water restriction, there was
a decrease in food consumption observed (see Fig 45 C). The ATF3 KO mice
showed a tendency to produce less urine than the WT mice but this difference
was not significant. There was a decrease in urine production after the water
deprivation, while 24 h after the mice were rehydrated, urine levels were back to
the former level in both groups of mice (see Fig. 45 D). Also the amount of feces
produced by the mice was similar for WT and ATF3 KO mice, after the water
deprivation, fewer feces were produced in both groups and the feces produced
were much drier (see Fig. 45 E).
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Figure 45: Characterization of WT C57BL/6 vs. ATF3 KO mice: A: The weight in
both groups changed in parallel during the experiment. After water deprivation there is a
clear loss in weight in both groups. B: Mice of both the WT or ATF3 KO group drank
same amounts of water which increased after the water deprivation on the third day of the
experiment. C: Food consumption was the same for both WT and ATF3 KO mice; it was
almost reduced by half after the day of water deprivation and increased to even higher levels
than in the beginning of the experiment when mice were rehydrated on day 4. D: Urinary
excretion constantly decreased in both groups over the course of the experiment. It reached
the minimum after the water deprivation phase and went back up to baseline levels after the
rehydration. There was no significant difference between the two groups of mice. E: Feces
production was parallel in WT and ATF3 KO mice. It first increased until the first day of
the experiment. After water deprivation, on the third day of the experiment, there were the
lowest amounts of feces excretion observed in both groups. Allowing the mice to drink water
again restored feces production to similar levels as on the days before. N=19. Error bars:
SEM.The separate results for males or females are represented in supplementary figure 3 and 4,
respectively.
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6.1 Potential role of ATF3 as aldosterone-induced gene product in the
kidney ASDN
The aim of this thesis was to gain more insight into the role of activating
transcription factor 3 in the kidney. The underlying observation that motivated
this aim was the fact that the ATF3 mRNA was 3.5-fold upregulated in the
aldosterone sensitive part of the nephron in a previous study [7]. So far no
other report has been published on a link between aldosterone and ATF3 in
the kidney. We initially hypothesized that aldosterone-induced ATF3 might
play a role in the action of aldosterone in the ASDN. Specifically the hypothesis
was that ATF3 would regulate the expression of genes that are involved in the
aldosterone-stimulated stabilization of ENaC in the apical membrane of epithelial
cells in the ASDN, its increased recruitment to the membrane and function and/or
the anabolic action of aldosterone, namely the increase of the energy providing
machinery, of the membrane surface etc. So far the key players in these events
are only partially known. Finding that a transcription factor is upregulated by
aldosterone opened a lot of new room for speculation about what happens between
the binding of aldosterone to its target gene promoters and the final increase in
Na+-transport via ENaC that is the outcome for the cell. ATF3 is a transcription
factor that dimerizes with itself and also forms heterodimers with various other
transcription factors, also from other transcription factor families. Depending
on the combination of the dimerization partner, ATF3 might either repress or
activate transcription of its target gene [29]. We wanted to find possible targets
of ATF3 to reveal players further down the line towards Na+-transport regulation
by aldosterone. It was reported that aldosterone has short term effects as well as
long term effects. A short term effect is represented in the upregulation of gene
transcripts that immediately affect Na+-transport via ENaC. The proteins formed
from these transcripts might then cause long term effects on the cells, for example
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by initiating differentiation, leading to formation of more mitochondria to meet
the increased energy needs that results from increased Na+- and K+-ion transport
rates. Furthermore during the differentiation the cells form many invaginations
of the basolateral membrane to make sure that the excess Na+ taken up by
ENaC apically can be released into the blood stream on the basolateral side of
the cell. Supporting this hypothesis, ATF3 regulates the expression of certain
proteins that are involved in gene differentiation. One example is the inhibitor
of differentiation (ID1). ATF3 binds to a target sequence in the ID1 promoter
and therefore inhibits transcription of the gen [48]. This would contribute to the
differentiation of the cell and rather inhibit it from proliferating further on. To
investigate the role of ATF3 in long-term aldosterone effects in vitro, namely in
the differentiation of the cell, we generated a mpkCCDCl14 cell model that shows
Dox-inducible overexpression of ATF3. The aim was to functionally investigate
this cell line in an Ussing chamber setup to test whether overexpressing ATF3
has an effect on transepithelial short circuit currents or transepithelial resistances,
both markers of differentiated principal cells. Furthermore it was planned to
investigate possible morphological effects of differentiation.
6.2 Cortical collecting duct cell lines to study the role of ATF3 in sodium
transport
The mpkCCDCl14 KRABATF3 transduced cells originally generated to study
ATF3 function on cell differentiation showed a considerable induction of expression
of the transcription factor when treated with Dox for 3 days (see Fig. 24-26).
However, when we performed functional tests in the Ussing chamber, neither the
transduced cells nor the WT cells seemed to respond to aldosterone stimulation by
increasing their transepithelial short circuit Na+ -currents. The work could not be
continued under these conditions, where the basic physiological response specific
for this cell line was not reproducibly observed. Trying various optimization
measures (change of FCS batch, media compositions, coating conditions of
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transwell filter growth supports, cell number etc.) did not change this fact (see.
Fig. 28). Contacting other laboratories working with the Ussing chamber and
principal cell lines revealed that also other research groups faced similar problems,
as well with another mouse cortical collecting duct cell line, the mCCDCl1. The
group of Prof. Olivier Staub isolated a new clone of this cell line the clone 6, which
reproducibly displayed the expected induction of transepithelial current upon
addition of aldosterone in Ussing chamber, which could be blocked with amiloride,
confirming that the induced current was a Na+-current mediated via ENaC (see
Fig. 29). Since the ability of the model cell line to respond to aldosterone by
increasing ENaC-mediated current was an absolute prequisite for our study, we
could therefore not use the ATF3KRAB overexpressing mpkCCDCl14 that had
been a time consuming work. In particular, the mpkCCDCl14 cells turned out
to be more resistant to lentiviral transduction than HEKT293 cells, HeLa cells
or MDCK cells that were used for GFP controls of virus infectivity (data not
shown). Since it was decided to use mCCDCl6 cells instead of the mpkCCDCl14
cells, we tried to transduce these cells with KRAB and ATF3 lentiviral constructs
as had been done previously for the mpkCCDCl14 cells. All attempts were not
successful. The GFP control construct revealed that the GFP expression was lost
within a few days, the transduction rates were very low (approximately 10-20%,
data not shown), suggesting that a stable insertion of the transduced gene did not
take place. In the context of the Ussing chamber studies with mpkCCDCl14 cells,
we also tested aldosterone induced ATF3 transcription in vitro in this cell line.
Surprisingly it was found that aldosterone itself did not have the expected effect
on the transcription factor and that it was rather the stress of a medium change
performed when adding the aldosterone to the cells that led to this effect.
6.3 Stress induction of ATF3 in cultured CCD cells and in mouse kidney
Based on the observation that the induction of ATF3 mRNA levels in mCCDCl6
WT cells is due to the medium change rather than to aldosterone, it was decided
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to adapt the focus of the project. The new focus was the characterization of
the stress-related induction of the transcription factor ATF3 in kidney epithelial
cells, how it is mediated and possibly its functional consequences. There are
numerous reports in the literature about ATF3 being an immediate stress-induced
gene and this has also been found to be true for the kidney. Mouse models
of ischemia-reperfusion kidney injury showed that an overexpression of ATF3
protected the kidneys from the insult compared to mice that had normal ATF3
levels. Since ATF3 is also found in urinary exosomes it has been suggested that
this transcription factor might be a marker for kidney injuries. We tested the
possibility that the ATF3 induction observed following aldosterone injection in
mice was analogous to the stress-induction of ATF3 observed in the in vitro
studies. Mice were injected mice with a physiological saline solution to test
whether the effect of restraining and injecting per se could have the same effect
on kidney cells as the in vitro medium change did. Working with animals, there
are at least two groups compared to eachother: a “non-treated” group vs. a
treated group. When animals are injected with a certain substance to provoke
a reaction of interest, there is always a second group that is injected with the
vehicle. This group is then considered as a “not-treated negative control”. The
need of a similar treatment of the control animals is substantiated by the study
of Rulter et al., who showed that injecting only saline i.p. into mice can have an
effect on gene expression of specific genes in the brain [111]. This report clearly
questions the reliability of results compared from two groups, a treated and an
untreated group when looking at gene expression. From the initial experiment
performed by Fakitsas et al. it had been concluded that ATF3 is upregulated by
aldosterone. In this study the control group was indeed untreated and sacrificed
without injection beforehand and the results of the more adequate control, namely
the mice injected with a mineralocorticoid receptor antagonist (canrenoate) had
not been used due to apparent technical problems. When the first evidence from
our in vitro experiments pointed out that ATF3 is stress-regulated rather than
aldosterone regulated, we decided to see if the injection of 0.9% NaCl / 0.3%
EtOH (this being the solvent from the original study that revealed ATF3 to be
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aldosterone related) per se could specifically upregulate ATF3. Like Rulter et
al., we also found that the i.p. injection of saline was enough to induce specific
mRNAs, in this case ATF3 mRNA in kidney. In contrast, this was not the case
for SGK1, a gene product induced by glucocorticoids and thus stress-sensitive.
The expression of a series of genes was measured not only in kidney but also in
brain, colon and heart. ATF3 levels were upregulated only in kidney, indicating
that this effect has a certain specificity.
6.4 Test of injection-stress induced ATF3 regulation in COPAS-sorted
tubule segments
Since ATF3 upregulation had originally been observed after aldosterone-injection
in the CNT/CCD micro-selected tubule material sorted by Fakitsas [7], it ap-
peared meaningful to test whether the effect of saline injection was present in
this tubule segment as well. To do so, green fluorescent CNT/CCD tubules from
a mouse that expresses EGFP in intercalated cells only under the control of the
B1 (V-ATPase subunit) promoter were sorted with a COPAS.
Unexpectedly the hypothesis that ATF3 mRNA levels might be strongest up-
regulated in the CNT/CCD due to the saline injection could not be confirmed.
Furthermore, there is only a tendency seen for ATF3 mRNA induction in negative
sorted fractions and whole kidney fractions. For these two fractions the RNA
quality was quite low in two samples per group, so we could only include an N=2
in our data analysis. This is why we cannot say that the ATF3 upregulation seen
in the two before mentioned fractions is significant; nevertheless, the tendency is
clearly distinguishable.
Thus, one reason why we were possibly not able to see the predicted upregulation
of ATF3 mRNA levels in the CNT/CCD sorted tubules by COPAS is rather
technical than biological: the sorting process takes 8 h which is considerably
long. The quality of the tubule preparation is crucial and depends mainly on the
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perfusion quality and also on the digestion in the collagenase solution. Kidney
tubules from mice where the perfusion failed to give nicely perfused kidneys had a
lower green fluorescence to start off with and this fluorescence decreased with time,
making the sorting process slower. Therefore the samples spent up to 8 h on ice.
It is possible that during this time certain species of mRNA are more degraded
than others. Moreover, since ATF3 is found in such low abundance in the kidney
as well as in other organs in general, it is likely that degradation of mRNA
soon reaches a level where ATF3 mRNA expression falls below the detectable
limit. Most probably there was also mRNA degradation for the other candidates
investigated, however mRNA levels e.g. for NaPi2a and NCC are much higher in
the kidney. Thus, detecting these species was still possible, even if there might
also have been less mRNA after 8h of sorting than at the time when the kidney
was extracted from the mouse. Furthermore samples were not cooled during the
sorting period of approximately 5 min. This might also be an explanation why
the effect on ATF3 mRNA observed in the first injection experiment (where the
whole kidney was lysed) was more pronounced than in the negative sorted and
the whole cortex fraction from the COPAS sorted tubules: The process of sample
preparation was indeed much faster for the initial experiment done with whole
kidney extracts than with the sorted tubules. When preparing kidney lysates
from whole kidneys, the organs were immediately snap-frozen after sacrificing
the animal for later processing of the tissue.
Testing the ATF3 protein expression in the selected tubule fractions was thus
not only crucial because the protein is the active product of a gene, but also
in regard of the suspected mRNA degradation that had taken place during the
tubule selection procedure. Importantly, Western blotting revealed indeed a
strong upregulation of ATF3 protein in the CNT/CCD sorted tubules of all
4 mice injected with the saline solution (see Fig. 43 A) compared to the 4
non-injected littermates. The ATF3 band detected in Western blot was at the
expected size of approximately 23 kD and was missing in the CNT/CCD tubules
sorted from B1EGFP ATF3KO mice. Indeed, as shown in Supplementary Fig. 7,
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a weak ATF3 band was seen in the non-injected B1EGFP WT mouse CNT/CDD
samples, whereas in constrast this band was always completely absent in the
B1EGFP ATF3 KO mice. As a control AQP2 protein expression was tested,
which was, as expected, not regulated by the stress of a saline injection (see
Suppl. Fig 6).
The goal of sorting CNT/CCD with COPAS was not only to test the effect of
injection on ATF3 mRNA expression in these kidney segments, but to also test
upstream and downstream factors of ATF3. Therefore the gene expression of
two candidates was measured: First, ATF4 which is found upstream of ATF3,
binding its promoter and increasing its transcription [110] [113]. ATF4 relative
mRNA levels were not altered in any of the mice or fractions studied. This
result suggests that the stress-induced activation of ATF3 in the saline injected
mice is not mediated via ATF4. However, this result needs to be considered
with caution in view of the probable mRNA degradation that took place during
the sorting procedure. Second, we studied CHOP10 which lies downstream of
ATF3. There is an ATF3 target site in the CHOP10 promoter, allowing it to bind
and to repress the expression of CHOP10. Interestingly CHOP10 itself actually
inhibits the function of ATF3 by forming a non-functional heterodimer with it
[114]. CHOP10 is able to bind to ATF3 because it also contains a leucine zipper
region, which allows the dimerization [115]. Thus, ATF3 represses the expression
of its own inhibitor [49].Therefore the expectation was that the levels of CHOP10
mRNA would be higher in the ATF3 KO B1EGFP mouse than in the B1EGFP
WT mice and possibly lower in mice that were injected with the saline solution,
due to upregulated ATF3. CHOP10 relative mRNA levels were by trend lower in
the negative sorted fractions of WT injected mice compared to negative sorted
fractions from WT mice that were not injected with the saline solution. However,
the ATF3 KO mice show the same low expression levels of CHOP10 as do the
injected WT mice. This does not support the notion that ATF3 KO mice would
have higher levels of CHOP10, due to the abundance of this repressor. Whether
another transcription factor can take over the role of ATF3 in repressing CHOP10
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transcription is not known. Also this result has to be considered with caution,
since apparently mRNA degradation took place during the sorting process (see
above for ATF3). Thus, additional experiments, in particular at the protein level
would be necessary to confirm the results for ATF4 and CHOP10 and to draw
reliable conclusions on how these two transcription factors are regulated by the
NaCl/EtOH-injection.
6.5 Lack of gross metabolic phenotype in ATF3 KO mice
The ATF3 KO mouse was so far only used to study pathological conditions,
such as different types of diabetes and involvement of the transcription factor
in immune reactions. The group of Prof. T. Hai (Ohio, USA) that originally
generated the mouse mostly takes interest in studying the effects of ATF3 in
pancreatic beta cell islets in diabetic mice. It has been shown that transplanting
pancreatic islets from healthy donors into diabetic rodents can normalize blood
glucose levels. However, transplanting islets is a difficult task and recipients
need to be immunosuppressed to do so. Hai et al. found ATF3 to contribute to
apoptotic cell death in WT pancreatic beta cell islets. Apparently ATF3 KO
islets show a better survival than the WT islets [116]. They also found ATF3
to be induced in mouse macrophages by lipopolysaccharide (LPS), a toxin that
is released from bacteria. LPS binds to Toll-like receptor 4 (TLR4) which is a
receptor on the endosome surface in macrophages. TLRs promote the formation
of toxic cytokines to contribute to the immune reaction caused by the LPS,
to help fight the infectious intruders. The role of ATF3 once induced by LPS
via TLR4 is to constitute a negative feedback loop that regulates the TLR4
signalling, keeping the macrophages from producing an unattenuated immune
reaction [117].
So far there was no characterization of ATF3 KO mice performed on the level of
basic physiological body functions like water and food uptake going along with
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urine and feces excretion. We hypothesized that since we found ATF3 to be
regulated specifically in the kidney upon stress, there might be a kidney phenotype
when knocking out the transcription factor compared to WT mice. Furthermore,
there was the possibility that ATF3 KO mice might not be able to respond
adequately to a stressor. Thus, we also performed a 23-h water deprivation in
the course of a metabolic cage experiment designed to test the gross parameters
mentioned above. No significant differences were observed between ATF3 KO
and WT mice for urine and feces excretion, food and water uptake and handling
the stress of a water deprivation (see Figs. 45 A-E). ATF3 KO mice showed a
tendency to be slightly lighter than the WT mice. Both groups of mice drank
about equal amounts of water and also increased their drinking similarly after
being re-supplied with water following the water deprivation. Moreover, WT as
well as ATF3 KO mice ate less during the time of water deprivation. This is most
probably due to the fact that the food was supplied as a dry powder, which was
less attractive when no water was provided in parallel. Urine and feces excretion
both decreased during the water deprivation to similar extents in both groups,
which paralleled the decrease in water and food intake. This is also why the mice
lost weight during this period. After the water deprivation the mice returned
to the baseline levels of urine and feces production as shown before the stress
period. Due to the very strict animal laws in Switzerland, the mice could only
be kept 4 days in the metabolic cages, preventing to further analyze how long
it took for the mice for normalizing their food and water intake. Nevertheless
we conclude that the kidneys of ATF3 KO mice seem to function normal and
are also able to respond to the stress of water deprivation as the kidneys of WT
mice do. Moreover, there was no difference between males and females found in
this experimental setup (see supplementary material Figs. 3 and 4).
It is not very surprising that the KO mouse of the transcription factor ATF3 is
viable and does not show any obvious phenotype. This is most probably due
to the mode of action of ATF3. Since it heterodimerizes with so many other
transcription factors, there might be for many of its actions redundant proteins,
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meaning that other transcription factors could take over the role of ATF3 in
the ATF3 KO mice. Other heterodimers might have similar effects on target
genes of ATF3, since there are numerous proteins from different families (ATF,
fos and jun) that form the so called AP-1 transcription factors of which ATF3
can form a part of. It is possible that ATF3 is replaced by other transcription
factors, which still allow the formed AP-1 transcription factor to regulate in
most cases gene expression similarly as when ATF3 constitutes one of the two
heterodimer-partners.
6.6 Signalling pathways involved in stress-induced ATF3 regulation in
cultured kidney cells
We were interested in which signalling pathways relay the stress-signal that induces
the upregulation of ATF3 in vitro by the medium change. There are various
reports about ATF3 being regulated mainly by the MAPK pathways, namely
JNK/SAPK [59], p38 and ERK [118] pathways. When treating mCCDCl6 cells
with different conditions of medium change, there was an increase in JNK/SAPK1,
p38 and ERK1/2 phosphorylation only when the medium had been previously
warmed in a tube in a 37 °C waterbath. For JNK/SAPK1, this phosphorylation
was accompanied additionally by an upwards shift of the total protein band in the
samples treated with the tube-pre-warmed medium change, suggesting that most
JNK/SAPK1 is modified to a slower migrating phosphorylated form under this
condition. We conclude that the upregulation of ATF3 due to the medium change
(as it is also shown in Fig. 35) might be mediated by all three MAPK pathways
studied herein, namely JNK/SAPK1, p38 and ERK1/2 signalling pathways.
Seven min after changing the medium (with medium pre-warmed in a tube),
phosphorylation of p38, JNK/SAPK1 and ERK1/2 is induced, meaning the
signalling pathways were activated by the stress of the medium change. Of course
after seven min the ATF3 expression is not altered that rapidly. The earliest
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time point at which ATF3 mRNA expression was studied after a medium change
was 30 min (see Fig. 22) in the case of mpkCCDCl14 cells. At this time point
its increase was already nearly maximal. The probable lag of ATF3 mRNA
upregulation after MAPKs have been phosphorylated (see Fig. 35) is that these
kinases per se do not act on ATF3 transcription directly, but that there are
several steps in between. Activated MAPK first phosphorylate transcription
factors which only then translocate to the nucleus and bind to target sequences
in the ATF3 promoter to influence its transcription rate. We do not know which
transcription factors are phosphorylated by the MAPK in this specific medium
change experiment. In the case of JNK/SAPK1 for example, target factors that
can be phosphorylated have been reported to include ATF2 [119], c-Jun [120] and
c-Myc [121], which act positively on ATF3 transcription. Thus we hypothesize
that p38, JNK/SAPK1 and ERK1/2 pathway are activated immediately by the
medium change, they then act on ATF3 which is visible after 30 min on mRNA
level (see Fig. 22 and 34) and after 1h at protein level (see Fig. 35). To find
possible interplayers between the MAPK phosphorylation and the subsequent
ATF3 mRNA upregulation, phospho-protein blots from cells treated with the
different medium changes should be performed to test the mentioned upstream
transcription factors. It would also be interesting to perform a timecourse
experiment similar to the one made with aldosterone addition (see Fig. 22), so
see after how much time a maximal induction of ATF3 protein by the medium
change is observed.
In all studies carried out so far, ATF3 is reported to be upregulated when the p38
or JNK/SAPK pathways are activated. For the ERK pathway the results of the
different studies are more opposing. ERK seems to have either a repressing or an
inducing effect on ATF3 expression, depending on the stimulus that provoked
the phosphorylation of the MAPK: While ERK repressed ATF3 transcription in
vascular endothelial cells [19] when activated by TNFα, there is also evidence
that when different cell types are exposed to UV-light, the activated MEKK1
phosphorylates ERK (and also p38) which leads to an increase in ATF3 mRNA
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levels [122]. Thus, in the case of our medium change experiments it is possible
that on one hand the activation of the ERK1/2 pathway contributes to the
upregulation of ATF3 mRNA via phosphorylation of transcription factors that
favor the induction of ATF3 transcription. On the other hand it is also possible
that ATF3 levels would be even higher in the tube pre-warmed medium change
condition, if ERK phosphorylation was prevented, since it might counteract the
effect of p38 and JNK/SAPK1. To find out if this is the case, one would have to
add specific inhibitors for ERK (e.g. PD98059) to the cell medium to test whether
this would increase or decrease upregulation after the medium change. The reason
that for one stimulus a MAPK pathway like the ERK pathway can stimulate ATF3
expression (e.g. UV-light) while its induction by another stimulus can inhibit
ATF3 expression (e.g. TNFα) is that there are other mediators acting between
phosphorylated ERK and ATF3 transcription and ATF3 protein accumulation.
Depending on the protein that is phosphorylated by the MAPK, activation
of the same signalling pathway might have dual effects on ATF3 expression.
In the case of UV-light, it is p53 that mediates the positive effect on ATF3
expression [122]. Tolfenamic acid (Ta) a non-steroidal anti-inflammatory drug
also upregulated ATF3 expression in cancer cells via the very same three MAPK
that we investigated. This is mediated by ATF2 phosphorylation and subsequent
binding of ATF2 to the ATF3 promoter [123]. It has also been shown that there
is crosstalk between the different MAPK pathways going on [124] [125]. This
makes the possibilities for regulation of gene transcription even more broad. The
use of specific inhibitors helps elucidating how the interplay between the MAPK
might influence the expression of a target gene like ATF3.
The before mentioned studies where ATF3 is reported to be induced by a certain
MAPK are usually carried out with very specific stimuli like cytokines (TNFα),
irradiation (UV-light) or cytotoxic agents (cis-platin, tolfenamic acid). Compared
to these extracellular signals, the medium change in the approach we used is
quite an unspecific stimulus. Several factors could actually mediate the MAPK
phosphorylation. To test whether it is the mechanical stimulation of the cell, due
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to the medium change we performed a mock change re-using the same medium.
This did not induce a significant change in ATF3 mRNA levels (see Fig. 34) and
had no effect on the protein level (see Fig. 35) as opposed to the medium change
with the tube pre-warmed medium. Also none of the MAPK that we investigated
was phosphorylated when cells were treated with a mock change only, as opposed
to a real change with medium pre-warmed in a tube. Therefore we could exclude
the mechanical stimulation to be the cause of ATF3 upregulation when changing
the medium. These results are also not compatible with the hypothesis that ATF3
induction was due to the detachment of cells as demonstrated in experiments
with keratinocytes anchored to the basement membrane via the glycoprotein
laminin 5 [126].
The original experiments made to test the effect of a medium change on ATF3
expression in mCCDCl6 cells were performed using medium that was pre-warmed
in a tube. We then realized that the medium might not have been equally CO2
equilibrated compared to the medium used for the mock medium change control.
Therefore we also tested the effect of medium that had been pre-warmed in the
incubator for 3h in 10 cm petri dishes to have a large enough surface for efficient
gas exchange. Apparently, it indeed made a difference on the phosphorylation of
JNK/SAPK1, p38 and ERK1/2. After seven min, when the medium used for the
change was pre-warmed in the tube, there was an increase in phosphorylation of
the three MAPK compared to non-treated controls. This was not the case with
the medium that had been pre-warmed in the incubator. Thus, we hypothesized
that this might be due to a higher pH due to a lack of CO2 equilibration. However,
this possibility was ruled out by measuring the pH, that was exactly 7.37 (data
not shown) for both media either pre-warmed in the incubator or in a tube.
Therefore it appears that the observed MAPK phosphorylation was not due to
the pH of the medium.
Furthermore, it can probably be excluded that the MAPK phosphorylation is
due to specific fresh medium ingredients, since for both medium changes either
pre-warmed in the tube or in the incubator, the same fresh medium was used. An
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additional possibility that could be excluded Is that replacing the medium was
actually removing an inhibitor. Indeed, in both cases the conditioned medium
was replaced with the same fresh medium, removing potential inhibitors.
Taken together, we can apparently exclude pH, temperature, medium composition
and mechanical stress as factors responsible for the phosphorylation of p38,
JNK/SAPK1 and ERK1/2 induced by a medium change in mCCDCl6 cells,
leading to an increase in ATF3 mRNA and protein levels after 1 h. The current
hypothesis is that this is due to the lack of CO2 in the medium. However, it still
remains to be positively demonstrated what factor is the cause of this effect.
6.7 Conclusion
From the present study we conclude that mpkCCDCl14 cells can be transduced
with lentiviral constructs to give stable and inducible cell lines for the gene of
interest, in this case ATF3. It is the first time that this has been possible for
this special cortical collecting duct kidney cell line. Achieving the same for the
mCCD cell line still remains an unreached goal. Our investigations show that
ATF3 is an early-induced stress response gene in the cortical collecting duct cell
line mCCDCl6 in vitro and also in mouse kidney in vivo. This stress-induction
of ATF3 is apparently mediated by the JNK/SAPK1, ERK1/2 and p38 MAPK
signalling cascadesin vitro. ATF3 stress-induction by NaCl/EtOH injection is
specific for the kidney and not for other organs tested. Moreover, the upregulation
of ATF3 by the injection-stress is also seen on the protein level in CNT/CCD
segments of the kidney. Furthermore ATF3 KO mice are not different from WT
littermates in terms of food and water consumption as well as feces and urine
excretion.
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6.8 Outlook
Further investigations on the nature of ATF3 upregulation in the whole kidney,
CNT/CCD tubules and mCCDCl6 cells due to stress of either injection or medium
change should be made. For instance, it still remains to be further confirmed
that the induction of ATF3 due to medium change is truly due to activation
of the investigated MAPK pathways. To do so medium change studies using
specific MAPK inhibitors against p38, ERK1/2 and JNK/SAPK1 should be
performed. This would also allow drawing conclusions about how the single
pathways contribute to the cellular response to the medium change. It is possible
that also other signalling pathways not involving MAPK phosphorylation are
involved in the upregulation of ATF3 expression in response to the medium
change. Possible candidates are the nuclear factor kappa B (NF?B)-signalling-
pathway [127], Akt-kinase signalling pathway and also transforming growth factor
beta (TGFβ) [64] signalling pathway, since they were all found to be involved in
the regulation of ATF3 expression. Furthermore, as mentioned in the discussion
the different mediators in the signalling pathways (e.g. ATF2, p53) that are
phosphorylated by the MAPK should be investigated. To obtain conclusive
results concerning the main factor responsible for the phosphorylation of MAPKs
upon medium change, the role of CO2 equilibration of the medium should be
clarified.
To really discern the role of injection-stress from that of aldosterone for the
upregulation of ATF3 in the CNT/CCD tubules, B1EGFP mice should be
either non-injected, saline-injected or aldosterone-injected for one hour and green
fluorescent tubules sorted with COPAS for subsequent qPCR analysis. In order
to perform this experiment there are several technical limitations that need to be
overcome, one being the breeding of the mice which had not been very efficient.
On the one hand the B1EGFP female mice show lower fertility than WT mice. On
the other hand the females also tend to eat their litters. Thus, breeding enough
mice of the same age and sex to obtain enough animals for additional COPAS
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experiments is a long process. Furthermore, at the moment the mice do not have
a complete C57BL/6 background. When the B1EGFP mice were shipped to Prof.
Carsten A. Wagner (University of Zurich, Switzerland) the mothers were pregnant
and had some pups that were brown, indicating that the transgenic mice created
with C57BL/6 x CBA F1 embryos were not backcrossed into C57BL/6 background
over an appropriate number of generations [106]. To obtain more reliable results
the mice would first need to be backcrossed into C57BL/6 background. Moreover
the sorting procedure when using the COPAS needs to be optimized, the sample
should be cooled at all times and the sorting time reduced drastically in order
to prevent RNA degradation. Furthermore, it seems crucial to analyze the
genes investigated with qPCR for their protein expression as well. Thus, for the
COPAS experiment shown in this study, ATF4 and CHOP10 expression should
be analyzed on the protein level to draw conclusions about the effect of the saline
injection on their expression.
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Supplentary figure 1: Expression of ATF3 and SGK1 mRNA in different organs upon
NaCl-Injection in WT C57BL/6 mice expressed relative to β-actin mRNA:: 3 mice
per group were either not treated or injected with 0.9% NaCl / 0.3% ethanol. All mice
were sacrificed after 1 hour. Subsequent total RNA extraction and qPCR shows upregulation
of relative ATF3 mRNA expression in the kidney about 4-fold due to injection of saline as
compared to mice that have not been injected until they were sacrificed. In brain heart and
mucosa scraped from the colon there was no difference in ATF3 expression observed between
the two groups. SGK1 mRNA expression is unaffected by injection of saline solution in all the
organs tested (kidney, heart, brain and colon mucosa, normalized to mouse β-Actin) *** = p
< 0.001 student t-test (unpaired), error bars: SEM. Fig. 39 of the main text shows the same
data relative expressed relative to HPRT mRNA.
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Supplentary figure 2: Relative ATF3 mRNA expression is induced due to medium
change in mCCDCl6 cells expressed relative to β-actin mRNA: mCCDCl6 cells were serum
and growth factor starved for 24 h. Cells either underwent no medium change, a mock change
where the medium on the cells was sucked up and put back on the cells immediately or a change
of medium replacing the old medium with fresh pre-warmed medium. The mock change of the
medium lead to an approximately 2-fold upregulation of relative ATF3 mRNA expression, while
a real medium change showed an approximately 5-fold increase of ATF3 mRNA expression
(normalized to mouse β-Actin).This was not observed for SGK1 expression. N=4; ** = p
< 0.01 student-test and 1-way ANOVA, error bars: SEM. Data expressed relative to HPRT
mRNA are shown in the main text in Fig. 34.
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Supplentary figure 3: Characterization of WT vs. ATF3 KO male mice: A:The weight
in both groups changed in parallel during the experiment. After day 2 of accommodation,
the ATF3 KO mice were lighter than the WT mice. After water deprivation there is a similar
loss in weight in both groups. B: Male mice of either the WT or ATF3 KO group drank
same amounts of water which increased after the water deprivation on the third day of the
experiment. C: Food consumption was the same for both WT and ATF3 KO male mice; it
was reduced after the day of water deprivation and increased back to normal levels when mice
were rehydrated on day 4. D: Urine excretion constantly decreased in both groups over the
course of the experiment. It reached the minimum after the water deprivation phase and went
back up to normal baseline levels after the rehydration. There was no significant difference
between the two groups of male mice. E: Feces production was parallel in WT and ATF3 KO
male mice, it first increased until the first day of the experiment. After water deprivation, on
the third day of the experiment, there were the lowest amounts of feces excretion observed
in both groups. Allowing the mice to drink water again restored feces production to similar
levels as on the days before. N=10 for WT males, N=9 for ATF3 KO males. Data pooled
from males and females are shown in the main text in Fig. 45.
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Supplentary figure 4: Characterization of WT vs. ATF3 KO female mice: A: The
weight of females in both groups changed in parallel during the experiment. After water
deprivation there is a similar loss in weight in both groups. B: Female mice of either the
WT or ATF3 KO group drank same amounts of water. The mice on both groups did not
drink a lot more than usual to compensate for the water deprivation on the fourth day of the
experiment. C: Food consumption was the same for both WT and ATF3 KO female mice
with a big drop on the day of the water deprivation. D: Urine excretion constantly decreased
in both groups over the course of the experiment. It reached the minimum after the water
deprivation phase. There was no significant difference between the two groups of female mice.
E: Feces production was parallel in WT and ATF3 KO female mice, it first increased until the
first day of the experiment. After water deprivation, on the third day of the experiment, there
were the lowest amounts of feces excretion observed in both groups. Allowing the mice to
drink water again restored feces production to similar levels as on the days before. N=10 for
WT females, N=9 for ATF3 KO females. Data pooled from males and females are shown in
the main text in Fig. 45.
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Supplentary figure 5: Characterization of COPAS-sorted tubule segment. Expression
of specific genes was compared in the different tubule fractions: GFP positive (CNT/CCD)
vs. GFP-negative tubules and total cortex tubules (N=12, except for ATF3 KO mice, where
values for ATF3 expression were excluded, N=8). Four mice per group (non-injected vs. 0.9%
NaCl / 0.3% EtOH injected for 1 h) and ATF3 KO B1EGFP C57BL/6 mice) were sacrificed
and kidney tubule suspensions were sorted with COPAS. Total RNA extraction and qPCR was
performed. ATF3 expression was highest in the CNT/CCD (GFP-positive fraction). ATF4 and
SGK1 expression were similar in all fractions while CHOP expression was observed to be lowest
in the CNT/CCD. All values of gene expression are relative to HPRT mRNA expression. *
compares WT non-injected to WT injected mice; $ compares WT non-injected to ATF3 KO
non-injected mice; # compares WT injected to ATF3 KO mice. *and $ = p< 0.05; ** = p <
0.01 with student t-test (unpaired), error bars: SEM.
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Supplentary figure 6: Effect of i.p. vehicle injection on gene expression in the different
tubule fractions compared to non-injected and ATF3 KO mice.The GFP-sorted fraction
(CNT/CCD), GFP-negative-sorted fraction and whole kidney cortex were sorted from WT
B1EGFP (non-injected vs. 0.9% NaCl / 0.3% EtOH injected for 1 h) and ATF3 KO B1EGFP
C57BL/6. Four mice per group were sacrificed and kidney tubule suspensions were sorted with
COPAS. Total mRNA extraction and following qPCR was performed. Gene expression was
normalized relative to HPRT expression in the different mouse groups and then normalized to
the non-injected mice (= 1). Relative levels of ATF3 mRNA were not altered by the stress
of NaCl/EtOH injection in the CNT/CCD (GFP positive) sorted fraction in WT B1EGFP
mice compared to non-injected WT B1EGFP mice (see main text Fig. 42). AQP2 and ENaC
expression were similar for all the groups tested within the different sorted fractions. The saline
injection lead to an apparent increase in NCC expression in the whole kidney fraction of WT
mice compared to non-injected WT mice. Also NaPi2a expression was lower in ATF3 KO
mice than in WT injected mice in the GFP-negative fraction. It is interpreted that the large
variation and apparent effects of the injection are probably due to uneven mRNA degradation
during the sorting procedure (see main text) N=4; except negative kidney fractions of WT
non-injected and WT injected mice (N=2). * compares WT non-injected to WT injected mice;
$ compares WT non-injected to ATF3 KO non-injected mice. $ = p < 0.05; ** and $$ = p<
0.01 with student t-test (unpaired), error bars: SEM.
 
Supplentary figure 7: ATF3 protein expression is upregulated due to injection of
NaCl/EtOH in CNT/CCD of B1EGFP WT mice: The GFP-sorted fraction (CNT/CCD)
of WT B1EGFP mice (non-injected (NI WT) vs. 0.9% NaCl / 0.3% EtOH injected (Inj WT)
for 1 h) and ATF3 KO B1EGFP mice were investigated for ATF3 protein expression. Western
blot analysis shows a clear induction of a band migrating at the expected size for ATF3 protein
(ca. 23 kD) in injected B1EGFP WT mice compared to non-injected littermates. Basal ATF3
expression in non-injected mice is almost not detectable in WT B1EGFP CNT/CCD tubule
lysates. The band is absent in non-injected ATF3 KO mice. Approximately 400 tubules were
loaded per lane, N=4, error bars: SEM.
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